Filters with echogenic characteristics

Abstract
There are described a variety of intravascular filters have wherein at least a portion of the filter has been modified to provide an enhanced echogenic characteristic of the filter.
Description
INCORPORATION BY REFERENCE

All publications and patents and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent or patent application was specifically and individually indicated to be incorporated by reference.


FIELD

Aspects of the invention described herein relate generally to filters inserted into a patient's body and more particularly to the provision of echogenic coatings on such devices to enhance their visibility using one or more of in any combination ultrasound imaging, intravascular ultrasound imaging, greyscale intravascular ultrasound imaging, color intravascular ultrasound imaging or ultrasound image signal processing that included spectral analysis.


BACKGROUND

Ultrasonic imaging in the medical field is widely used for a variety of applications. In addition to imaging physiological structures and tissue such as organs, tumors, vessels, and the like, it is often desirable for a physician or technician to have an image of a medical device which has been inserted into the tissue or passageway of a patient. Still further, advancements in the use of intravascular or intraluminal imaging ultrasound (positioned either within or outside of the body) before, during and after procedures has led to increasing requirements for cooperation between device and imaging modality.


A variety of approaches have been used to enhance ultrasonic imaging of devices by increasing the acoustic reflection coefficient of the devices. While echogenic materials have been described for some uses in medical devices, the conventional uses of echogenic materials has not kept pace with the advancements in applications for imaging ultrasound. Moreover, while many approaches have been attempted, there is still need for improvements that are particular to the use of specific device designs. In particular, as medical therapies and procedures continue to advance, there is, in many medical instances, a need for more specific information about a device, its placement, position, orientation or aspect in relation to another object. What is needed are further improvements to the manner and placement of echogenic enhancements to obtain these additional benefits.


SUMMARY OF THE DISCLOSURE

In general, in one embodiment, a filter includes a hub; and a plurality of legs or wires or segments extending from the hub; wherein at least a portion of the hub or a portion of one or more of the legs or wires or segments is modified to provide an enhanced echogenic characteristic of the filter.


This and other embodiments include one or more of the following features. In one aspect, the modification can provide an enhanced echogenic characteristic of the filter is a modification to a portion of the filter to enhance the echogenic characteristics of that portion of the filter. In another aspect, the modification can provide an enhanced echogenic characteristic of the filter which can be the formation of dimples into a surface of the filter. In yet another aspect, the dimples can be of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with an intravascular ultrasound system. In a further aspect, the modification can provide an enhanced echogenic characteristic of the filter which can be the formation of protrusions formed in, placed on or joined to a filter surface. In an additional aspect, the protrusions can be of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with an intravascular ultrasound system. In another aspect, the modification can provide an enhanced echogenic characteristic of the filter including the roughening one or more surfaces of a filter. In yet another aspect, the roughening can be performed using a chemical process, a laser or bead blasting technique. In still a further aspect, the roughening can be of sufficient scale to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems. In a further aspect, the modification can provide an enhanced echogenic characteristic of the filter including altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of the filter. In an additional aspect, the cavities, voids or pockets can be of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with an intravascular ultrasound system.


This and other embodiments include one or more of the following features. In one aspect, the filter can further include at least one fixation element. Any portion of the tissue anchor or any portion of one of the hub, the plurality of legs or wire or segments extending from the hub can be modified to provide an enhanced echogenic characteristic of the filter related to the use, status, position orientation of the at least one fixation element or the filter. In another aspect, the first and second support members, the crossover and the first end or the second end of the first support member, any portion of one of the above can be modified to provide an enhanced echogenic characteristic of the filter related to the use, status or of clot burden of the filter. In a further aspect, a method of positioning a filter within a lumen can include advancing a sheath containing a filter through the lumen, deploying a portion of the filter from the sheath into the lumen while maintaining a portion of the filter within the sheath, either of the above steps can be performed before or after using imaging from an intravascular ultrasound system. In an alternative aspect, a method of deploying a filter within a lumen can include advancing a sheath containing the filter through the lumen; and deploying the filter into the lumen, wherein, either step can be initiated, performed, confirmed or completed at least in part based on information obtained using intravascular ultrasound from one or more echogenic aspects of the filter. In yet another aspect, the method can further include maneuvering a snare towards the filter in a direction to retrieve the filter and engaging the snare with the filter. The maneuvering step or the engaging step can be initiated, performed, confirmed or completed at least in part based on information obtained using intravascular ultrasound from one or more echogenic aspects of the filter. In still another aspect, the method can further include engaging the lumen wall with a fixation element attached to the filter. This step can be initiated, performed, confirmed or completed at least in part based on information obtained using intravascular ultrasound from one or more echogenic aspects of the filter. In one aspect, a filter delivery catheter can be adapted and configured to deliver a filter according to any of the previously mentioned embodiments. A delivery catheter can be adapted and configured for delivery of an endoluminal filter, an IVUS transducer can be integrated into the distal portion of the delivery catheter, and one or more connectors on the proximal end of the delivery catheter can be adapted and configured to connect the IVUS transducer to an appropriate imaging or processing system. In another aspect, the filter delivery catheter can further include a telescoping sleeve within an moveable relative to the filter delivery catheter. In yet another aspect, the filter delivery catheter can further include a pusher rod within a moveable relative to the filter delivery catheter. In still another aspect, the IVUS transducer integrated into the distal portion of the delivery catheter can be adapted and configured whereby advancing and retracting the delivery catheter generates a plurality of images slices from the IVUS transducer. In a further aspect, the IVUS transducer integrated into the distal portion of the delivery catheter can be adapted and configured whereby advancing and retracting the delivery catheter can provide an output from the IVUS transducer for positioning guidance of a filter delivered using the delivery catheter. Is an alternative aspect, the IVUS transducer can be integrated into the distal tip or end of the delivery catheter. In yet another aspect, the delivery catheter can further include a pressure transducer. In still another aspect, the pressure transducer can be located proximal to the IVUS transducer. In one aspect, the delivery catheter can further include a filter as in any of the previously mentioned embodiments within the delivery catheter. In another aspect, a method of positioning a filter within a lumen can include advancing a delivery catheter according to any of the previously mentioned embodiments and can contain a filter as in any of the previously mentioned embodiments through the lumen using imaging information provided by the IVUS transducer on the delivery catheter to determine relative position before deploying a portion of the filter from the delivery catheter into the lumen to engage the lumen wall. In yet another aspect, the method can further include obtaining IVUS imaging of the lumen using the delivery catheter prior to deployment of the filter, after the deployment of the filter or during the deployment of the filter. In still another aspect, the method can further include obtaining IVUS imaging of the lumen using the delivery catheter for imaging a deployment location and estimating the sizing of a filter for the deployment location prior to performing any of the previously mentioned methods. In a further aspect, the method can further include estimating treatment duration using imaging data collected as in any of the previously mentioned methods. In an alternative aspect, a filter can further include an IVUS transducer integrated into the filter.





BRIEF DESCRIPTION OF THE DRAWINGS

A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIG. 1 is a section view of a wire strut or support element of a filter (w/s/s) having multiple segments in a concentric arrangement.



FIG. 2 is an embodiment of a segment having one or a plurality of laser drilled holes formed therein.



FIG. 3 is an embodiment of a segment having one or a plurality of raised features or alternatively roughed portions formed thereon.



FIG. 4 is an embodiment of a segment having one or a plurality of bubbles formed therein.



FIG. 5 is an embodiment of a segment having one or a plurality of dimples formed therein.



FIG. 6 is an embodiment of a segment having a coil or braided structure within or about the segment.



FIG. 7 is an embodiment of a segment having a plurality of echogenic markers arrayed in rings about the segment to provide an indication of measurement via the spacing between adjacent rings.



FIG. 8 illustrates various alternative configurations for a segment used alone or in conjunction with other segments.



FIG. 9 is a view of an exemplary filter illustrating various alternative aspects of providing a filter with improved echogenic characteristics.



FIG. 10 is an end view of the filter as it appears looking toward the apical hub forming a part of the filter.



FIG. 11 is a sectional view through the center of the apical hub forming a part of the filter, and illustrating the manner in which the legs of the filter are positioned in the apical hub and are retained therein.



FIG. 12 is a side view of an embodiment of the blood clot filtration device.



FIG. 13 is a perspective view of a vena cava filter embodiment showing the head and legs thereof.



FIG. 14 is a perspective view of a vena cava filter showing the head and legs thereof.



FIG. 15 is a perspective view of a thrombus filter.



FIG. 16 is a plan view of the anchor portion of a thrombus filter.



FIG. 17 is a schematic representation of a removal process for use with a thrombus filter.



FIG. 18 is a schematic representation of a thrombus filter drawn into the lumen of a removal catheter.



FIG. 19 is a fragmentary elevation view of the blood clot filter embodiment in a totally straightened position.



FIG. 20 is an elevation view of the blood clot filter in a partially straightened position.



FIG. 21 is a perspective view of a portion of the inferior vena cava and having a section removed to show the configuration of the blood clot filter in its implanted and anchored position within the inferior vena cava.



FIG. 22 is a perspective view of an alternative blood clot filter having two V-shaped struts and a tangle of fine wires.



FIG. 23 is a view of a filter in place in a vein.



FIG. 24 is a side view of a blood clot filter.



FIG. 25 is an embodiment of a filter in its unfolded state.



FIG. 26 is a side of the filter in an expanded position.



FIG. 27 is a view illustrating the filter by chain dot lines in a collapsed condition.



FIG. 28 shows schematically in perspective a filter its unfolded state.



FIG. 29 is an isometric view of a filter.



FIG. 30 is an elevation of a vena cava filter shown in its fully expanded state.



FIG. 31 illustrates an embodiment of a filter, seen in perspective.



FIG. 32 is a perspective view of a filter device, placed in position in a vein.



FIG. 33 is an isometric view of an embodiment of an embolus trap.



FIGS. 34A-34C illustrate an example of a guidewire having both a pressure sensor and an IVUS transducer located at the distal portion of the guidewire.



FIGS. 35A-35D illustrate two embodiments of an intravascular ultrasound catheter joined together in parallel with a catheter.



FIGS. 36A and 36B, the pressure sensor and/or IVUS transducer are integrated into a delivery catheter, a retrieval catheter or a device itself.





DETAILED DESCRIPTION

Filters are more complex structures in contrast to the relatively simple designs found in catheters and needles. In a more complex device like a filter there is a need to identify specific portions within the device during some medical procedures. In addition, it would be advantageous as well to determine the orientation of the device including components within the device to one another (as used for determining deployment, retrieval and the various intermediate stages thereof) as well as the overall filter orientation to the surrounding lumen or vessel. In contrast to the conventional techniques using location of the tip or start or end of the entire length, a more complex structure such as a filter position, orientation or relative placement information would yield specific benefits. In some cases, aspects, portions or attributes of the overall filter or filter components or portions will enable more useful determinations about the filter in relation to the physiological environment. In one aspect, an intravascular ultrasound (IVUS) catheter and processing system or signal processing algorithm is used to confirm filter sizing selection, guidance for filter placement, filter implantation steps, filter and/or vessel measuring using IVUS before during and/or after steps to confirm sizing selection and fit is appropriate under the physiologic environment and for confirmation and/or documentation of proper sizing selection, placement, engagement or degree of engagement of fixation elements (if present), clot burden, orientation and/or deployment in a patient or physician medical record.


In one aspect, embodiments of the present invention are directed toward medical devices having a complex shape or that are configured to move from stowed to deployed configurations that may also have specific orientation and placement criteria for proper use in a lumen, vessel or hollow organ. One such complex device is an IVC filter. Aspects of the present invention include such devices employed within the human body which have enhanced ultrasound visibility by virtue of incorporation of an echogenic material using any of the techniques described herein alone or in any combination.


In one aspect, there are described herein various alternative filter designs for increasing the echogenicity of the filter. A filter with enhanced echogenic characteristics may include one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. One example of the manufacturing alteration is to introduce gaps between the segments of tubing or coverings whereby the gap provides the echogenic enhancement. In addition, cavities, voids, pockets, dimples, gaps and the like may be left empty or, optionally, filed, partially filed or lined with any of the echogenic materials described herein.


In one aspect, there are provided embodiments of a filter having enhanced echogenic characteristics in or related to at least one or a portion of: an proximal end, a distal end, a terminal proximal end, a terminal distal end, a retrieval feature, an atraumatic tip on a retrieval feature, a mid-strut region, a leg or strut portion having at least one orientation attribute to another portion of the filter, an indicia of a location of a fixation element or a retrieval feature, a location on a portion of the filter selected such that in use with a particular fixation element the marker in in a location that indicates that the fixation element is fully deployed into a wall of a lumen or portion of a vessel or hollow organ (i.e., the marker is against the lumen wall or nearly so when the fixation element is fully engaged. As such, see the marker against the wall indicates proper deployment, spaced from or not visible would indicate, respectively, not fully engaged or over penetration); a portion of the distal tip and/or an elongated portion. The above described methods may also be applied to the other techniques and alternatives described herein.


In still further embodiments, a portion, component or aspect of an intraluminal filter may have enhanced echogenic attributes by applying a coating or sleeve containing one or more of the echogenic materials disclosed herein or fabricated according to any of the techniques or having any of the attributes to enhance echogenic qualities as described herein. In some aspects, the enhanced echogenic attributes are provided by the incorporation into, application onto or within a component or portion of a filter one or more echogenic materials or echogenic markers in a specific configuration, location, orientation or pattern on the filter.


Enhanced echogenic markers or locations may be devised and placed for use individually or in combinations such as to facilitate the identification to an IVUS system or ultrasound imaging modality an indication or signature for a specific location on a filter, such as, for example, a retrieval feature, a terminal proximal end, a terminal distal end, a location of a fixation element or a location of some other indicia that identifies a specific aspect of a particular filter design. In addition or alternatively, two or more enhanced echogenic markers or portions may be used in combination to provide additional information about a filter such as orientation with in a vessel, confirmation of deployment or a portion of a deployment sequence, confirmation of final placement, confirmation of migration or lack of migration, confirmation of retrieval or progress in a retrieval sequence and the like according to the various processes and used for filters within the vasculature or in lumens of the body. In another specific embodiment, the use of IVUS techniques with embodiment of the echogenic enhanced filters describe herein may also be used to measure the diameter of the vessel at specific device locations indicated by the echogenic markers during or after deployment or retrieval of a filter.


In still further aspects, the use of IVUS techniques with embodiment of the echogenic enhanced filters describe herein may also be used to determine, detect or indicate inadequate dilation, adequate dilation, filter expansion, degree of filter expansion, filter—vessel engagement and degree or engagement, strut/leg/anchor position and other attributes relating to the interaction between the filter and the surrounding physiological environment.


Still further, the echogenic markers are positioned with regard to the likely or planned positioning of the IVUS transducer and/or likely pathways for acoustic energy used by the imaging system. By way of example, if the IVUS transducer is forward looking, then those forward looking aspects of the filter will be provided with the enhanced echogenic aspects. In another example, if the IVUS transducer is cylindrically shaped and will be positioned through the interior portion of a filter then the filter will be provided with enhanced echogenic aspects on interior surfaces or portions that would receive acoustic energy from such as transducer in such a position. Other modifications are within the scope of the invention based on the particular style of IVUS transducer used, the position relative to the filter and the placement and type of echogenic feature incorporated into the filter. Put another way, the echogenic enhancements of the filters described herein are selected, designed and positioned on the filter with regard to the IVUS sensor type, acquisition mode and position relative to the filter. Additional details in the use of IVUS with filters is further described in U.S. Pat. Nos. 6,645,152 and 6,440,077, both of which are incorporated herein by reference in their entirety for all purposes.


In one aspect, the placement and signature of such enhanced echogenic markers are discernible to a human user viewing an ultrasound output alone or in combination with being discernible to a computer system configured for the processing of an ultrasound return including a return from the enhanced echogenic filter.


In various alternatives, the echogenic material may either be applied to a portion of or a component of a filter in any of a number of different techniques.


In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a selective coating applied to a portion or component of a filter.


In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a mold formed to be placed over or joined to a portion of component of a filter.


In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as an extruded sleeve formed in a continuous segment to cover a portion or component of a filter. In one embodiment, one of the inner tubular member or the outer sleeve or coating may be fabricated of a material according to the present invention, having increased echogenicity, with the other of the inner tubular member fabricated of a biocompatible polymer such as polyurethane or silicone rubber, for example.


In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a compound or two layer structure comprising an inner tube and an outer tube or sleeve with one or both of the tubes made from or including or incorporating one or more echogenic materials or modifications as described herein. In addition or alternatively one or both sleeves, tubes described herein may include or encapsulate an echogenic marker or component of specific shape or geometry, for example, as in the case of a tube structure having within the sidewall of the tubing a coiled structure. In one aspect, the coiled structure is made from an echogenic material and the windings are provided in a manner that is useful in any of the aspects of the filter described herein. The coil may have a particular size or variation in size, pitch or variation in pitch or other attribute useful in providing an echo identifiable aspect of the filter property being determined. In one specific embodiment, the dimensions of the coil or other echogenic material has dimensions selected for increasing acoustic reflection with regard to the resolution or processing algorithms used in the imaging ultrasound system.


In one example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a braided structure incorporated into a compound or two layer structure comprising an inner tube and an outer tube or sleeve with one or both of the tubes made from or including or incorporating one or more braid comprising echogenic materials or modifications as described herein. In addition or alternatively one or both sleeves, tubes described herein may include or encapsulate an braid formed into an echogenic marker or component of specific shape or geometry, for example, as in the case of a tube structure having within the sidewall of the tubing a braided structure. In one aspect, the braided structure is made from an echogenic material and the braided is a small diameter that is when wound around the tubes or sleeve or directly onto a portion of or component of a filter. The winding pattern and spacing of the braided materials are provided in a manner that is useful in any of the aspects of the filter described herein. The braid may have a particular braid strand composition, structure, size or variation in size, pitch or variation in pitch or other attribute useful in providing an echo identifiable aspect of the filter property being determined. One or more of the strands in the braid may be formed from an echogenic material. One or more of the strands may be formed from a material having improved radiopaque characteristic. One or more of the strands may be formed from a material having both echogenic and radiopaque properties. The strands of a braid may be combined using any of the above described strand characteristics.


In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as the a series of short segments placed adjacent to one another along a portion or component of a filter in either a close packed or spaced arrangement. In another embodiment, the spacing or voids between adjacent segments may also be adjusted or selected so as to enhance echogenic capabilities of the filter using the material difference introduced by the spacings or voids.


In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter as a tubing or sleeve suited to heat shrink operations. In one aspect, there is a manufacturing or assembly steps of sliding one or more sleeves over portion of the filter then apply heat to shrink down the segment about the portion of the filter. In particular, various embodiments provide for the specific placement of such a shrink fit tubing having enhanced echogenic characteristics as described herein. It is to be appreciated that the sleeves, segment or tubes may be provided from or have echogenic modifications or elements incorporated into suitable materials such as, for example, ePTFE, PTFe, PET, PVDF, PFA, FEP and other suitable polymers. Still further, these and other materials may be formed in shapes other than tubes but may also take the form of strands, lines, fibers and filaments to be applied in accordance with the echogenic enhancement techniques described herein. In some embodiments, the tubes or segments applied to a filter may have the same or different composition as well as have the same width or different widths. In one aspect, the width or thickness of a plurality of bands is used to provide a code or information about the filter. The use of echogenic bands of different widths is a marking technique similar to the way that different size and color rings on a resistor are arranged in a pattern to describe the resistor's value.


In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter is extruded over a portion of or a component of the filter.


In another alternative, in still another example, an echogenic component or additive is applied to or incorporated into a filter or portion of a filter is by bonding an echogenic material or components to the filter using a suitable adhesive or bonding technique.


In any of the above described configurations, the portion or component of the filter may be modified with dimples, grooves, pockets, voids. In other aspects, there may be one or more full or partial circumferential recesses, rings, surface diffraction gratings or other surface features to selectively enhance or provide an echogenic property in that portion of the filter, to aid in or foster the application of the echogenic materials. In still further aspects, any of above described surface modifications may also be used to uniquely identify a portion of a filter or any of the above in any combination.


In still further aspects of any of the above echogenic markers or attributes the thickness of the sleeve or coating or component may decrease at its proximal and distal ends to provide for a smooth outer surface. As yet an additional alternative, a coating, marker or other echogenic material may extend proximally to or closely adjacent to the distal end or the distal end or both of the filter component or filtering device.


In still other alternatives or combinations, some filter design embodiments alter components of the filter to enhance echogenicity such as, for example, material selection to incorporate echogenic materials. Examples of echogenic materials include palladium, palladium-iridium or other alloys of echogenic materials.


In some embodiments, echogenic microbubbles are provided in a portion of a filter to enhance the acoustic reflections of that aspect of the filter. Echogenic microbubbles may be prepared by any convenient means and introduced into the component or portion thereof or by a coating or sleeve or shell or other transferring means or mixed with a polymer or other suitable base compound prior to extension of extrusion, molding casting or other technique. The echogenic microbubbles may be pre-prepared or prepared inside the component or element or marker as appropriate. Aspects of the preparation or use of microbubbles are described in U.S. Pat. Nos. 5,327,891; 4,265,251; 4,442,843; 4,466,442; 4,276,885; 4,572,203; 4,718,433 and 4,442,843. By way of example, echogenic microbubbles can be obtained by introducing a gas, e.g. carbon dioxide, into a viscous sugar solution at a temperature above the crystallization temperature of the sugar, followed by cooling and entrapment of the gas in the sugar crystals. Microbubbles can be formed in gelatin and introduced into a component or portion of a device. Microbubbles can also be produced by mixing a surfactant, viscous liquid and gas bubbles or gas forming compound, e.g. carbonic acid salt, under conditions where microbubbles are formed.


In still further alternatives, there is also the incorporation of dual mode materials (radiopaque and echogenic) into a polymer then used to form part of, be applied or otherwise incorporated with a filter device as described herein. Some of these polymer compounds may be fabricated to enhance aging and shelf life and have other beneficial attributes. In one aspect, a filter or portion thereof includes one or more selected segments that are constructed using visibility materials compounded with one or more polymeric materials that make the selected segments visible using both fluoroscopy and ultrasonic imaging. In one specific example, the visibility material may take the form of tungsten and/or tungsten carbide particles dispersed within a polymeric material. In one specific aspect, the radiopaque and echogenic material includes tungsten and/or tungsten carbide particles distributed within a base polymeric material.


In one embodiment, a portion of or a component of a filter includes or has been modified to have an inner layer including a radiopaque and echogenic material. In one alternative, the radiopaque and echo genic material includes particles distributed within a base polymeric material (i.e., a first polymeric material) including a polyether block amide; and an outer layer including an additional polymeric material (i.e., a second polymeric material). In certain embodiments, the additional polymeric material is a thermoplastic elastomer. Optionally, the additional polymeric material is more resistant to hydrolysis and/or oxidation than the base polymeric material.


In still further aspects, a component, a portion or an element added to a filter may be regarded as an echogenic body member that is a part of an echogenic filter to be sonically imaged. The echogenic body member is at least partially made up of a composite material which is echogenically imageable in the patient, such as by the use of ultrasonic imaging equipment used either within the patient or external to the patient. In one aspect, a composite material includes matrix material with discrete acoustic reflective particles embedded in matrix material. In one aspect, the matrix material is a biocompatible plastic. Examples of suitable plastics may include urethane, ethylene, silicone, polyethylene, tetrafluorethylene. In one aspect, a matrix is a formable, pliable material which may be molded and/or extruded to a variety of shapes, depending upon a specific application. The sound reflective particles are embedded in matrix material. Particles are, by way of example, made of a hard material, such as small glass particles that are solid or filled with an acoustically reflective medium. In one aspect, glass particles having a generally spherical shape forming glass microspheres. Glass microspheres with an outer diameter of about 5 microns is one acceptable size. Other sized particles may be utilized as, for example, ranging between 1 and 50 microns and beyond. Particles sized below the resolution size of the imaging ultrasound system in use may be arranged into patterns of sufficient size and orientation to the acoustic waves that result in a discernible feature by the imaging ultrasound system. Furthermore, the particles do not necessarily have to be spherical, or may be partially spherical. Still further, the shape of the particle could be altered to enhance acoustic reflection by presenting different shapes of particles, sizes of particles and combinations thereof to modify acoustic characteristics of the matrix material. By way of example, the particles may be shaped into an “Ordered array.” “Ordered arrays” can take the form of a macrostructure from individual parts that may be patterned or unpatterned in the form of spheres, colloids, beads, ovals, squares, rectangles, fibers, wires, rods, shells, thin films, or planar surface. In contrast, a “disordered array” lacks substantial macrostructure.


By way of example, an echogenic marker may comprise particles that individually are below the resolution of the imaging ultrasound system. The echogenic marker is the combination of these below imaging ultrasound resolution particles in combination, in 1D, 2D or 3D patterns, in graphic arrays, or in machine readable combinations to make a signature. Based on the specific characteristics of the combination of particles, the acoustic returns from an echogenic marker or combination of echogenic markers may be visually perceptible in a display for interpretation by a user or may be detected and interpreted by one or more acoustic reflection or spectral processing algorithms within a imaging ultrasound processing system.


In one aspect, the echogenic material is fabricated by incorporating nanometer sized particles of sonically reflective materials, for example iron oxide, titanium oxide or zinc oxide into a biocompatible polymer. In one method of fabrication, the acoustically reflective particles are mixed with a powdered thermoplastic or thermosetting material such as a polyether amide, a polyurethane or an epoxy, or polyvinylchloride followed by thermal processing of the mixture to provide a material of increased sonic reflectance which may be applied as a coating on medical devices of the type discussed above or may be incorporated as a structural component of the medical devices as described herein.


In still further embodiments and aspects, the particles included to provide echogenic enhancements may be selected, arranged or incorporated to provide acoustically geometrically tuned nanostructures, microstructures or macrostructures. The particles provided herein are formable in all shapes currently known or to be created for acoustic reflection enhancement. In non-limiting examples, the nano-, micro- or macro-particles are shaped as spheres, ovals, cylinders, squares, rectangles, rods, stars, tubes, pyramids, stars, prisms, triangles, branches, plates or comprised of an acoustically reflective surface or where one or more surfaces is adapted such as by roughening or dimpling or other technique used to alter acoustic reflection properties. In non-limiting examples, the particles comprise shapes and properties such as plates, solid shells, hollow shells, rods, rice shaped, spheres, fibers, wires, pyramids, prisms, or a combination thereof.


In one specific aspect, a partially spherical surface may be provided on the outside and/or the inside of particles, as for example a particle with a hollow spherical space therein. Particles are made up of a different material than the matrix. While desiring not to be bound by theory, it is believed that a spherical shape provides for sound reflections at a variety of angles regardless of the direction from which the ultrasonic sound waves are emanating from, and accordingly, are more likely to reflect at least a portion of the transmitted signal back to the ultrasonic receiver to generate an image. Since many of matrix materials available are relatively ultrasonically transparent in a patient, sound reflective particles provide adequate reflection. The use of a composite, rather than a solution, provides adequate size for acoustic reflection off of the discrete particles embedded in the matrix. As indicated, a variety of materials may be utilized for the sound reflective particles, such as aluminum, hard plastic ceramics, and, metal and/or metal alloys particles, and the like. Additionally, liquids, gases, gels, microencapsulants, and/or suspensions in the matrix may alternatively be used either alone or in combination, so long as they form a composite with the desired ultrasonically reflective characteristic.


Any of the above embodiments, alternatives or filter modifications to enhance echogenic characteristics may also be designed or implemented in such a way as to provide an echogenic identifiable or unique trait or acoustic reflection signature that may be registered by a human operator looking at a display or identified using signal processing techniques of a return containing acoustic reflections from the filter in an imaging ultrasound system. In one example, there is a surface of the filter having one or more echo registerable or identifiable feature, mark or indication in a position useful for determining one or more of: a location of an end of a filter; a location of a fixation element on a filter; a location of a retrieval feature on a filter; an orientation of one or more of a leg, a strut, a filter or an end of a filter relative to another of a leg, a strut, a filter or an end or the orientation of the overall filter to a lumen, vessel or hollow organ in a body. Moreover, in another widely applicable aspect of providing enhanced imaging characteristics to a filter as described herein, the characteristic or modification—however added or incorporated into the filter—enable a filter, a filter component or a specified portion of a filter to be more readily imaged by intravascular ultrasound as described herein. In still another aspect, the characteristics or modification to the filter are oriented and positioned in order to facilitate IVUS imaging via an IVUS probe borne by a filter deployment or retrieval catheter, snare, or other implement provided to facilitate the use of intravascular filters.



FIG. 1 is a section view of a wire strut or support element of a filter (w/s/s) having multiple segments in a concentric arrangement. In this illustrative embodiment, the wire is encased in alternating tube segments. There is an inner tube (IT) directly adjacent to the wire. There is an echogenic segment layer (EL) adjacent to the inner layer. The inner tube may be selected to act as bonding layer to increase adhesion between the echogenic layer and the filter wire, strut or support member. In this embodiment, there is an outer tube (OT) over the echogenic layer. In alternative configurations, either or both of the inner tube or the outer tube may be omitted. The echogenic layer is a segment having one or more of the echogenic characteristics described herein.



FIGS. 2-7 provide various exemplary embodiments of a segment 87 having one or a plurality of one or more than one type of echogenic characteristic, property or feature added thereto. Each of the illustrated echogenic adaptations applied to segment 87 along with segment 87 itself may be sized, scaled and/or shaped as described herein as needed based upon the requirements of the portion of the filter and the echogenic characteristic.



FIG. 2 is an embodiment of a segment 87 having one or a plurality of laser drilled holes 88 formed therein. The diameter and the shape of the holes may be selected based upon the size of the filter or filter component to which the segment 87 will be attached. The holes 88 may be completely through the wall of the segment or only partially through the wall. The holes 88 may be formed in any pattern, spacing or orientation as described herein.



FIG. 3 is an embodiment of a segment 87 having one or a plurality of raised features or alternatively roughed portions 89 formed thereon. The size and shape of the raised features or the roughness of the surface may be selected based upon the size of the filter or filter component to which the segment 87 will be attached. The raised features or portions of roughness 89 may be formed in any pattern, spacing or orientation as described herein.



FIG. 4 is an embodiment of a segment 87 having one or a plurality of bubbles 90 formed therein. The size, shape, pattern, and manner of incorporating one bubble 90 or a plurality of bubbles 90 into the segment 87 may be selected based upon the size of the filter or filter component to which the segment 87 will be attached. The bubbles 90 may be formed within the segment sidewall, near the surface of the segment sidewall or near the inner surface of the sidewall. The bubble or bubbles 90 may be formed in any pattern, spacing or orientation as described herein.



FIG. 5 is an embodiment of a segment 87 having one or a plurality of dimples 91 formed therein. The diameter and the shape of the dimples may be selected based upon the size of the filter or filter component to which the segment 87 will be attached. The dimples 91 may be formed in any pattern, spacing or orientation as described herein.



FIG. 6 is an embodiment of a segment 87 having a coil or braided structure 92 within or about the segment 87. The size, shape, pattern, and manner of incorporating the coil or braid 92 into the segment 87 may be selected based upon the size of the filter or filter component to which the segment 87 will be attached. The coil or braid 92 may be formed within the segment sidewall, near the surface of the segment sidewall or near the inner surface of the sidewall. The coil or braid 92 may be part of a sandwich structure as illustrated and described in FIG. 1. The coil or braid 92 may be formed in any pattern, spacing or orientation as described herein to enhance the echogenic characteristics of the filter or filter portion attached to the segment 87. The coil or braid 92 may be continuous along the entire length of a segment 87 or, alternatively, the coil or braid 92 may be in short lengths selected so that a plurality of coils or braids are provided within a single segment 87.



FIG. 7 is an embodiment of a segment 87 having a plurality of echogenic markers 93 arrayed in rings 93.1, 93.2 and 93.3. For purposes of illustration the rings are shown in an orientation that is generally orthogonal to the central longitudinal axis of the segment 87. The rings are shown with a sample spacing of 1 cm between them. The spacing may be any suitable distance based on the factors described herein such as filter size and physiological environment. Similarly, the rings may be angled in other orientations relative to the longitudinal axis of the segment. For example, some ring may be in one angular orientation while other rings may be in a different angular orientation where the angular orientation or patent of orientation is utilized to provide one or more of the filter functionality or echogenic characteristics described herein. In some specific configurations, the spacing and sizes used are in the millimeter range. In some specific configurations, the spacing and sizes are in the micron range. In some specific configurations, the size and/or spacing of a ring or between adjacent rings are in a combination of mm and micron ranges for sizes, spacings and features. The size and spacing of the echogenic markers 93 may be selected based upon the size of the filter or filter component to which the segment 87 will be attached. The markers 93 may be formed in any pattern, spacing or orientation as described herein in order to facilitate a measurement using the markers. Still further, the markers 93.1, 93.2 and 93.3 may be utilized for provide for other filter characteristics as described herein.



FIG. 8 illustrates various alternative configurations for a segment used alone or in conjunction with other segments. The segments are illustrated along an exemplary wire, strut, or component of a filtering device. The segments may have different characteristics to enable the segment to be more readily imaged by a medical imaging modality used externally, internally or intraluminally. In one aspect, the segment characteristics are selected to provide for imaging enhancements for a filter being used within a vein or an artery. In another aspect, the segments may have different characteristics to enable the segment to be readily imaged by intravascular ultrasound as described herein. In still another aspect, the segments are oriented and positioned in order to facilitate IVUS imaging via an IVUS probe borne by a filter deployment or retrieval catheter, snare, or other implement. In one illustrative embodiment, the segments are selected and arrayed to facilitate imaging utilizing IVUS and an external medical imaging modality. In one exemplary embodiment, the external imaging modality is x-ray.


Also illustrated in FIG. 8 is the use of a combination of different echogenic characteristics (designated E) and radio-opaque characteristics (designated RO). These characteristics may be any of those described herein in any combination. The echogenic characteristic of a segment may be the same as another segment in a grouping such as in the E segments 87.9 and 87.5. Alternatively, the echogenic characteristic of a segment may be different from those in an adjacent group as with segments 87.2, 87.5 and 87.7.



FIG. 8 also illustrates not only that different characteristic and properties of segments may be used but also how variable segment dimensions may be used to aid in echogenic enhancement of a filter. As illustrated, the segments have different widths or thicknesses as indicated along the longitudinal axis of the wire, strut or component. As such, FIG. 8 illustrates a series of imagine enhancing segments 87.1-87.10 having a variety of width or thickness values t1-t10. In one embodiment, the segments are configured as short rings or bands. The thickness of segments in groups may be similar as illustrated in segments 87.1, 87.2 and 87.3 where the thicknesses t1, t2 and t3 are about the same. Similarly, segments 87.4, 87.5 and 87.6 illustrate segments of similar width or thickness where t4, t5 and t6 are about the same value. Similarly, segments 87.8, 87.9 and 87.10 illustrate segments of similar width or thickness where t8, t9 and t10 are about the same value.



FIG. 8 also illustrates how segments within a group or groups of segments may have a variety of different spacing (s1-s6) to provide enhancements to a filter for improving medical imaging modality characteristics. For example, in the segment grouping of 87.1, 87.2 and 87.3, there is a spacing s1 between segment 87.1 and segment 87.2 but then no spacing between segments 87.2 and 87.3. A spacing s2 is shown between segment 87.3 but then no spacing in the combination segment grouping formed by segments 87.4, 87.5 and 87.6. A spacing of s3 is shown between the three segment combination of 87.4, 87.5 and 87.6 to the single segment 87.7. The single segment 87.7 is spaced apart by spacing s4 from the equally sized (i.e., t8=t9=t10) and equally spaced (i.e., s5=s6) group of segments 87.8, 87.9 and 87.10. It is to be appreciated that in various alternative embodiments, the spacing used in groups of segments or between groups of segments may be the same or variable.



FIG. 9 is a view of an exemplary filter illustrating various alternative aspects of providing a filter with improved echogenic characteristics. The filter illustrated is a conical filter. It is to be appreciated that the filter of FIG. 9 is merely representative of one type of filter. It is to be appreciated that the various alternative enhancement, modifications and treatments described herein may be provided to any intravascular or intraluminal filter. The exemplary filter is dividing into three general sections A. B and C. Sections A, B and C may be the same type of enhancement or have an enhancement different from one another section. In addition, the type of enhancement in each section may be the same or different from one another in detection, response or appearance under ultrasound. In addition, a tag, feature or enhancement may be different within a section. Circles 902 are used to indicate exemplary locations for an echogenic feature, tag, marker or modification to an enhanced filter 10. The illustrative embodiment in FIG. 9 also illustrates a continuous echogenic layer, feature or modification or treatment 908. The illustrative embodiment in FIG. 9 also illustrates an echogenic attribute on/near an inflection point 906 in an enhanced filter structure 10. The illustrative embodiment in FIG. 9 also illustrates a segmented echogenic layer, feature or modification or treatment 904 on an enhanced filter structure 10. Section A is considered the apex, tip, distal portion or terminal end depending upon filter configuration. Section B is considered the mid-strut, middle, filtration portion, debris capture portion, or thrombus collection or lysing portion depending upon specific filter configuration. Section C is considered the rear portion, proximal portion, proximal terminal portion, anchor, fixation or perforation portion depending upon a specific filter configuration. It is to be appreciated as well that the echogenic features, tags, markers or modifications illustrated for sections A, B and/or C may be of the same type or different types depending upon the echogenic signature or attribute intended for that section, group or sections or filter. As such, the echogenic features, tags, markers or modifications for a particular section may be selected from any of the various alternatives described herein.


Echogenic characteristics may be added to each of the sections based on the type of function being measured or characterized. For example, echogenic markers, features or tags may be added to Section A in order to provide, for example: identification of the terminal end, end portion or retrieval portion of a filter. Echogenic characteristics of Section A may also be used for determinations related to Section A specifically or the filter generally of filter position, positioning, attitude within the lumen, localization of the filter within the vasculature and other traits common to the characterization of intravascular devices. For example, echogenic markers, features or tags may be added to Section B in order to provide, for example: identification of the mid strut portion, middle or capture region. Echogenic characteristics of Section B may also be used for determinations related to Section B such as for sizing, centering, symmetry of implantation, placement, apposition of implant to vessel walls, clot burden, deployment status or completion, gauge of filter capacity and/or filter contents as well as filter position, positioning, attitude within the lumen, localization of the filter within the vasculature and other traits common to the characterization of intravascular devices. For example, echogenic markers, features or tags may be added to Section C in order to provide, for example: identification of the rear portion, terminal end, retrieval feature, anchor location or depth of insertion, perforation indication or other aspects of the rear or proximal portion of a filter. Echogenic characteristics of Section C may also be used for determinations related to Section C such as for sizing, centering, symmetry of implantation or placement of legs struts and the like, as well as for determination of wall apposition, anchor penetration or perforation. Still further, the markers or tags may be added to aid in determining or evaluating filter position, positioning, attitude within the lumen, localization of the filter within the vasculature and other traits common to the characterization of intravascular devices.


A filter having enhanced echogenic properties is illustrated in FIG. 9 as it appears when it is in operative position within the vasculature. In one specific aspect the filter is in use in a large blood vessel. One exemplary vessel is the vena cava. Still further, a modified filter may be employed in a different vein or even an artery. The filter is designated generally by reference numeral 10, and the wall of the blood vessel in which it is located is designated by reference numeral 12. The filter 10 includes an apical hub 14 of overall egg-shaped or tear drop configuration and which has a generally hemispherically shaped end portion 14a.


The filter 10 includes a plurality of elongated legs 16 which are of equal length and are identically configured to each other. The legs 16 are collectively arrayed in a conical geometric configuration so that the legs converge to the apical hub 14, and are symmetrically spaced about a central axis extending through the hub. Each of the legs is of equal diameter over its entire length and is made of a relatively resilient material, such as tempered stainless steel wire or the like. In addition to the echogenic attributes described herein, the legs may be coated with a polymeric, synthetic resin material having anti-thrombogenic properties. FIG. 9 illustrates an echogenic marker at the tip 14. Exemplary continuous echogenic layers, features or modifications are also illustrated along one or more legs of the filter. In addition, FIG. 9 illustrates the use of echogenic tags, features or markers at, along or near inflection points in a filter element or component. In addition, FIG. 9 illustrates to application of echogenic markers, tags or features near the fixation elements of the filter.



FIG. 9 is a view of an IVC filter having an improved echogenic characteristic. A filter constructed in accordance with the invention is illustrated in FIG. 9 as it appears when it is in operative position within a large blood vessel, such as the vena cava. The filter is designated generally by reference numeral 10, and the wall of the blood vessel in which it is located is designated by reference numeral 12. FIG. 10 is an end view of the filter in FIG. 9.


The filter 10 includes an apical hub 14 of overall egg-shaped or tear drop configuration and which has a generally hemispherically shaped end portion 14a. This construction avoids impalement of the filter on the blood vessel walls during emplacement, and also avoids irritation or scratching of the blood vessel during insertion of the filter. The apical hub 14 is drilled for the reception of the end portions of a plurality of legs as hereinafter described.


The filter 10 includes a plurality of elongated legs 16 which are, in some embodiments, of equal length and are identically configured to each other. In one aspect, the legs 16 are collectively arrayed in a conical geometric configuration so that the legs converge to the apical hub 14, and are symmetrically spaced about a central axis extending through the hub. Each of the legs is of equal diameter over its entire length and is made of a relatively resilient material, such as tempered stainless steel wire or the like. The legs may be coated with a polymeric, synthetic resin material having anti-thrombogenic properties. In the embodiment of the filter illustrated, six of the legs 16 are provided, and since each of these legs is identical to every other leg, only one of the legs will be described in greater detail.


At its outer end, or end which is distally located with respect to the apical hub 14, each leg is reversely bent through an angle of more than 90°, and is tapered or sharpened to a point 16a. The reverse bend is outwardly in a direction away from the central axis of the conical figure. As depicted in FIG. 11, the end portions of the several legs 16 project into bores formed through the apical hub 14, and are secured in the hub by suitable techniques.


It will be seen in FIG. 9 that when the filter 10 is positioned in the blood vessel, the points 16a at the divergent ends of the legs 16 hook into or impale the wall 12 of the blood vessel, but the hooks are not of sufficient size to penetrate or pass through the wall of the blood vessel. It will further be noted by reference to the arrow within the blood vessel in FIG. 9 that when the blood flows in the direction indicated by the arrow, the pressure exerted by the blood on the filter 10, and any embolus which may be entrapped thereby, tends to set the hooks at the divergent ends of the legs 16 into the wall 12 of the blood vessel so that dislodgment of the filter is resisted.



FIG. 12 is a view of a breakaway anchor portion of an IVC filter having an improved echogenic characteristic. Referring to FIG. 12, an embodiment of the blood clot filtration device 10 of the invention consists of six legs 12 protruding from a head or nosebead 14. The legs 12, e.g., wire of diameter DW, about 0.018 inch (0.5 mm), each have: a first linear leg portion 13 lying parallel to axis E of the filter, for distance HN, e.g., about 1 mm, a nose bend 15, a second multi angled leg portion 16 of relatively greater length than the first linear leg portion, angling outwardly from the distal end of the first leg portion away from axis E, to define, with other second leg portions, an imaginary cone with base 20, shown as dotted lines; and outwardly directed hooks 22. The second leg portions 16 consist of a series of discrete linear segments arrayed generally tangent to the surface of the imaginary cone in a manner to increase the efficiency of the filtering effect. The diameter of the base of the filter is DB, about 38 mm, and the overall length of the filter is L, about 50 mm. The linear leg portions 13 of all of the legs are closely arranged in a hexagonal pattern about central leg stub or segment 24 and the ends of all of these legs are joined at the apex in proximal head or nose bead 14, formed by fusing the ends of legs 12 and central leg stub 24 together.


The wires forming legs 12 are formed into first linear portion 13, second multi angled portion 16 and hook 22 against a steel guide in such a way that there is an alternating bend circumferentially oriented to produce a characteristic conical structure. Hook 22 has length LH, about 1.8 mm, and is angled at angle θH, about 34°. The bends 38 in leg wires 12 are formed by bending the wires at an angle of 130°-150°. Hook 22 is formed mechanically by bending the distal end of wire 12 over a mandrel. Hook 22 is then sharpened on three sides against an abrasive wheel. Nose bend 15 is made to form first linear portion 13 near to bead 14, parallel to axis E of filter 10. The leg 12 then bends slightly outwardly on the major angle of the cone and passes through a series of bends as described above.


The embodiment of the filter described above with regard to FIG. 12 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIG. 12 may be modified according to FIGS. 1-9 above.



FIGS. 13 and 14 are of an IVC filters having an improved echogenic characteristic. Referring now to FIG. 13, there is shown a first embodiment of a vena cava filter 10 having an apical hub or head 14 of generally cylindrical shape.


The filter 10 includes a plurality of elongated legs 16 which are of equal length, and are preferably identically configured to each other. The legs 16 are collectively arranged in a generally conical geometric configuration so that the legs 16 converge in the apical head 14, and are symmetrically spaced about a central longitudinally disposed axis “L”, which is shown extending through the head 14, in FIG. 13. The legs are of equivalent diameter, being about 0.018 inches in diameter fabricated from stainless steel or titanium wire, and are of about 2.02 inches in final length. In the embodiment of the present invention, six legs are provided, however only one will be described in detail.


At its outermost end 18 which is distal with respect to the apical head 14, each leg 16 has a main portion 20 and a reversely bent portion 22 which is bent through an angle of about 180° in the plane which is tangential to the conical configuration of the legs, and is disposed parallel and contiguous to the main portion 20. A pointed tip portion 24 of the leg which comprises a hook, extends generally radially outwardly, away from the main portion 20 at an angle of from 70° to about 90°, which tip portion 24 is shown piercing a cava wall 26.


A further embodiment of a vena cava filter 60 is shown in FIG. 14 having an apical head 62. The filter 60 includes a plurality of elongated legs 64 which are of equal length, and are configured identical to each other. The legs 64 are collectively arranged in a slightly outswept but generally conical configuration so that the legs 64 converge in the head 62, and are symmetrically spaced about a central longitudinally disposed axis “L”, which is shown extending through the head 62 in FIG. 13. The legs are about 0.018 inches in diameter fabricated preferably from stainless steel, only one of the legs being described in detail. Each leg has an outermost or distal end 66 with a hook configuration disposed thereon.


A typical leg 64 is each mounted in a bore 68 in the apical head 62, which bore may be parallel to the center line of the filter 60. Each bore 68 receives only about 0.19 inches of the proximalmost end of each leg 64. When all the legs 64 are filling their proper respective bores 68, they are preferably welded therein. Each leg 64, in addition to having a plurality of U-shaped bends 70, disposed in the plane tangential to the cone defined by the legs 64, and intermediate their proximal and distal ends, as recited in the aforementioned incorporated patent, has a first slight bend 72 having a radius of curvature RI of about 1.4 inches arranged immediately adjacent the apical head 62, to cause the leg(s) 64 to flare radially outwardly about 18 degrees, thus defining their cone shaped configuration. This flare permits the filter 60 to have enough elastic recoil to assume its general conical configuration, which is desirable to permit the filtration of blood clots while still allowing blood to flow around the captured clots, thus promoting dissolution of any clot and maintenance of vessel patency. The filter 60 with this flare can be passed through small delivery carriers without exceeding the elastic limit of the stainless steel filter legs 64.


The apical head 62 on the filter 60 has a central cylindrically shaped bore 80 which is adapted to receive inself aligning engagement, a guidewire (not shown). The bore 80 critically has its cylindrical portion which is in axial alignment with the longitudinal center line “L” of the filter 60. Each end of the bore 80 has a tapered counterbore 82 to permit access of a guidewire into the bore 82. This permits the filter 60 to be aligned and centered along the axis of a guidewire in a vessel during (and after) filter emplacement therein.


The embodiment of the filter described above with regard to FIGS. 13 and 14 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIGS. 13 and 14 may be modified according to FIGS. 1-9 above.



FIG. 15 is a view of an IVC filter having an improved echogenic characteristic. FIG. 15 is a perspective view of a thrombus filter 20. Thrombus filter 20 includes a body member 22 and a plurality of elongated struts 24. Struts 24 each have a joined end 26 and a free end 28. Joined end 26 of each strut 24 is fixedly attached to body member 22.


Struts 24 may be fabricated from wire with a circular or rectangular cross section. For example, struts 24 may be comprised of 2 inch lengths of 0.018″ diameter wire. Stainless steel, titanium, and nickel-titanium alloys have all been found to be acceptable materials for struts 24. In the embodiment of FIG. 15, a plurality of bends 25 are disposed between free end 28 and fixed end 26 of each strut 24. It should understood that struts 24 may also be straight, or include bends different than those illustrated in FIG. 15, without departing from the spirit of scope of the present invention.


In the embodiment of FIG. 15, body member 22 is generally cylindrical in shape, and includes a bore 23. It should be under stood that other embodiments of body member 22 are possible without departing from the spirit or scope of the present invention.


Struts 24 radiate outwardly from body member 22 such that thrombus filter 20 is generally conical in shape. When thrombus filter 20 is deployed inside a blood vessel, free ends 28 engage the blood vessel wall. Body member 22 is held in a position proximate the center of the blood vessel by the plurality of struts 24 which engage the blood vessel walls with opposing force vectors.


When thrombus filter 20 is disposed in a blood vessel, the conical formation of struts 24 acts to trap, or capture blood clots. The generally conical shape of the formation of struts 24 serves to urge captured blood clots toward the center of the blood flow. The flow of blood around the captured blood clots allows the body's natural lysing process to dissolve the clots.


To assure firm attachment of thrombus filter 20 to the blood vessel walls, anchor portions 30 may be formed at free ends 28 of struts 24. FIG. 16 illustrates one embodiment of an anchor portion 30 embedded in a vessel wall 32. Anchor portion 30 includes a sharp point 34 and a bend 36. Strut 24 includes a weakened portion 40 disposed proximate free end 28. In the particular embodiment of FIG. 16 weakened portion 40 includes a plurality of divets 42. Divets 42 substantially reduce the cross sectional area of strut 24 at weakened portion 40. Divets 42 may be fabricated by removing material from strut 24 with a removal process such as machining or grinding. Divets 42 may also be fabricated by displacing material with a process such as metal forming or crimping.


Blood vessel wall 32 is lined with a thin inner membrane or intima 44. When anchor portion 30 is embedded in wall 32 it punctures inner membrane 44. The body responds to a puncture of inner membrane 44 with a process known in the art as neointimal hyperplasia. The punctured area of inner membrane 44 is overgrown with a number of new cells. Referring again to FIG. 16, it can be seen that anchor portion 30 of strut 24 is covered with encapsulating cell growth 46.


It is desirable that the thrombus filter of the present invention can be removed using minimally invasive methods without complications due to neointimal hyperplasia encapsulation of anchor portions 30 of struts 24. A process which may be utilized to remove thrombus filter 20 from a blood vessel 90 is schematically represented in FIG. 17.



FIG. 17 schematically illustrates a blood vessel 90 including a lumen 92 and walls 32. Thrombus filter 20 is disposed in lumen 92 of blood vessel 90. Anchor portions 30 of struts 24 are embedded in walls 32 of blood vessel 90. Neointimal hyperplasia has resulted in encapsulating cell growth 46 proximate anchor portions 30 of struts 24.


A removal catheter 100 with a lumen 102 and a distal end 104 is also disposed in lumen 92 of blood vessel 90. Removal catheter 100 enters the patient's vascular system at a point which is readily accessible to the physician. Once in the vascular system, catheter 100 is urged forward until distal end 104 is proximate thrombus filter 20. For example, if thrombus filter 20 is located in the inferior vena cava of a patient's vascular system, removal catheter 100 may enter the vascular system at the femoral vein. Alternately, if thrombus filter 20 is located in the superior vena cava of a patient's vascular system, removal catheter 100 may enter the vascular system at the jugular vein. In either case, the filter removal procedure can be minimally invasive, and not require general anesthesia.


Distal end 104 of removal catheter 100 is urged forward so that body member 22 of thrombus filter 20 is disposed inside lumen 102 of removal catheter 100. A force F is applied to thrombus filter 20 urging body member 22 further into lumen 102 of removal catheter 100. The magnitude of force F is of sufficient magnitude to break struts 24 at weakened portions 40. When struts 24 are broken at weakened portions 40 thrombus filter 20 including struts 24 may be pulled into lumen 102 of removal catheter 100. Removal catheter 100 may then be removed from the body of the patient by withdrawing removal catheter 100 from blood vessel 90. Thus, thrombus filter 20 is removed from blood vessel 100 but anchor members 30 remain attached to walls 32 by encapsulating cell growth 46.



FIG. 18 is a schematic representation of thrombus filter 20 after it has been pulled into lumen 112 of retrieval catheter 110. As may be seen in FIG. 18, pulling thrombus filter 20 into lumen 112 of retrieval catheter 110 causes struts 24 to collapse. When struts 24 are collapsed, retrieval catheter 110 may be withdrawn from blood vessel 100. As can also be seen in FIG. 18, anchor members 30 remain fixed in the walls of blood vessel 100, retained by encapsulating cell growth 46.


Force F may be applied to thrombus filter 20 using a variety of methods. For example, the pulling of thrombus filter 20 into lumen 112 of retrieval catheter 110 may be accomplished with a retrieval wire including a hook. The retrieval wire may pass through bore 23 of body member 22. With the retrieval wire disposed in bore 23 of body member 22, the hook may engage body member 22 so that a pull force can be applied to thrombus filter 20.


Struts 24 may also be intentionally broken at weakened portions 40 by repeatedly deflecting struts 24 to induce fatigue cracking at weakened portions 40. The magnitude of the force required for this removal method is less than the magnitude of force required to break struts 24 without fatigue cracking.


A number of methods may be used to deflect struts 24. First, a pull force may be applied to thrombus filter 10 as shown in FIG. 17. Applying a pull force to thrombus filter 20 deflects blood vessel walls 32 and struts 24. When the pull force is released, blood vessel walls 32 and struts 24 deflect a second time in returning to an unstressed position. Pulling force F may be applied and released repeatedly to induce fatigue cracking at weakened areas 40. It should be noted that the pull force applied when using this removal method is not sufficient to break struts 24 at the outset. However, multiple applications of force F cause fatigue cracks to grow at weakened areas 40. As described above the cross-sectional area of struts 24 is reduced at weakened areas 40 by slots, holes, and the like. The cross-sectional area of struts 24 is further reduced by fatigue cracking due to repeated applications of force F. After multiple applications of force F, the cross-sectional area of struts 24 at weakened areas 40 will be small enough that force F alone is sufficient to break struts 24 at weakened areas 40.


The embodiment of the filters described above with regard to FIGS. 15-18 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIGS. 15-18 may be modified according to FIGS. 1-9 above.



FIG. 19 is a view of an IVC filter having an improved echogenic characteristic. FIGS. 19 and 20 show a blood clot filter of the clot filter assembly designated at 10. Filter 10 is shown in a totally straightened position in FIG. 19 with its wire strands slightly spaced apart so that the construction of filter 10 may be more clearly seen. FIG. 20 shows filter 10 in a partially straightened but also somewhat curled position. It should be understood that filter 10 would normally assume the shape of a curly wire mesh unless external forces are employed to straighten the wire strands. It is also to be understood that filter 10 would be provided to the physician in a prepackaged assembly additionally including a cartridge catheter and a wire guide handle, both of which will be more fully described herein.


Filter 10 includes six strands of stainless steel wire which are connected to each other in the following manner. Innermost strands 11 and 12 are mutually attached at both ends by crimps 13 and 14. Innermost strands 11 and 12 are approximately 25 centimeters in length and are made from 0.007 inch diameter coil wire. Outermost strands 15 and 16 are located oppositely of innermost strands 11 and 12 and are each connected thereto at both ends by wire strands 17 and 18. Outermost strands 15 and 16 are approximately 38 centimeters in length and are made from 0.007 inch diameter coil wire. Wire strand 17 serves to connect outermost strands 15 and 16 with innermost strands 11 and 12 at the distal end of filter 10. In a similar manner, wire strand 18 connects outermost strands 15 and 16 with innermost strands 11 and 12 at the proximal end of filter 10. Wire strand 17 is secured to outermost strands 15 and 16 by crimps 21 and 22, respectively and to innermost strands 11 and 12 by crimp 13. In a similar fashion, wire strand 18 is secured to outermost strands 15 and 16 by crimps 19 and 20, respectively, and to innermost strands 11 and 12 by crimp 14. Wire strands 17 and 18 are approximately 10 centimeters in length and are made from 0.010 inch diameter stainless steel coil wire. Crimps 19-22 are made from 3 mm, of 22 GTW cannula while crimps 13 and 14 are made from 3 mm, lengths of 19.5 GTW cannula. Innermost strands 11 and 12, and outermost strands 15 and 16 are made from a shape memory material, such as spring temper stainless steel.


During manufacture, wire strands 11, 12, 15 and 16 are curled in different directions and wadded together to form a curly wire mesh. Because of their shaped memory construction, innermost strands 11 and 12 and outermost strands 15 and 16 may be straightened out at their ends substantially as shown in FIG. 19 for loading into the lumen of a Teflon angiography catheter cartridge. It may be noted that once loaded within the catheter, the spring bias inherent within the wire strands will cause some curling thereof. Further curling is, of course, restrained by the intimal wall of the catheter cartridge. Thus, it is the spring bias inherent in the shape memory construction which allows filter 10 to expand radially outward as innermost wire strands 11 and 12 and outermost wire strands 15 and 16 contract along their lengths upon insertion in a body blood vessel, as will be more fully explained herein.


Anchoring filter 10 within a body blood vessel, such as the inferior vena cava, is generally provided by fixation elements at 24 and 25, the details of their construction being more clearly understood by reference to FIG. 20. It is to be understood that anchor 24 is located at the rearward end of both wire strands 15 and 16, while anchor 25 is located at the forward end of both wire strands 15 and 16. Anchor 24 differs from anchor 25 due to the presence of a barb 30 whose purpose will become fully apparent hereinafter. The anchor 24 and 25 at the ends of outermost wire strand 15 are longitudinally staggered from the corresponding anchor 24 and 25 at the ends of outermost wire strand 16. This permits the easy loading of filter 10 within the lumen of a catheter cartridge such as will be more fully described herein.


Referring particularly to FIG. 20, the details of construction of the rearward anchoring means 24 will now be described. It is to be understood that while only the rearward anchor 24 at the end of outermost wire strand 15 is described, the rearward anchor means 24 at the end of outermost wire strand 16 is of a similar construction. It is seen that rearward anchor means 24 includes a length 26 of outermost wire strand 15 located at the rearward end thereof. Length 26 is approximately one centimeter in length and has a sharp end point 27 which is meant to enter the wall of a blood vessel. In order to prevent too deep penetration of anchor 24 through the blood vessel, a loop 28 of wire formed from wire strand 18 is positioned adjacent length 26. Loop 28 extends approximately 7 mm along length 26, crimp 19 serving to secure the end of loop 28.


It is to be understood that there are two forward anchor 25 at the forward end of filter 10. As previously mentioned, forward anchor 25 is of a similar construction to anchor 24 except that a barb 30 is received over the end length of wire corresponding to length 26 of anchor 24. The purpose of barb 30 is to provide a more secure anchor at the downstream end of filter 10 and thereby ensure long term patency of the filter. Barbs 30 are secured to the forward ends of the outer most wire strands 15 and 16 by soldering. Each of the barbs 30 have a lancet beveled portion 31 which faces outwards of filter 10 and a hooked portion 32 at the inwards facing end. Hooked portion 32 serves to prevent barb 30 from becoming dislodged from the body blood vessel once penetration thereof has been made. Each of the barbs 30 is constructed from 6 mm, to 0.028 inch diameter cannula.



FIG. 21 show filter 10 in its longitudinally contracted and radially expanded position within the inferior vena cava of a human body. It is to be noted that in this position filter 10 is in the shape of a curly wire mesh with spaces therethrough no larger than 3-4 mm. Also, due to the relatively small diameters of the wire strands, filter 10 occupies only a minimal portion of the cross-sectional area of the blood vessel passageway. Thus, filter 10 does not substantially occlude the blood vessel passageway. Also, barbs 30 extend into the intimal wall of the inferior vena cava in such fashion so as to firmly anchor filter 10, thereby ensuring long term patency.


In addition to the anchoring points at barbs 30, FIG. 21 also shows filter 10 in urging contact with the intimal wall 70 of the inferior vena cava 65 at innumerable other points along the lengths of various portions of the wire strands of filter 10. Initially, these points of urging contact do not provide sufficient anchoring to ensure patency of filter 10, thus requiring the anchoring provided by barbs 30. However, after several weeks endothelization and fibrotic encasement occurs at the points where the wire mesh of filter 10 abuts the intimal wall of the inferior vena cava, and the likelihood of permanent patency is thereafter greatly increased.



FIG. 22 is an alternative embodiment similar to FIG. 20. FIG. 22 includes 2 V-shaped struts supporting the fine wires as described above.


The embodiment of the filter described above with regard to FIGS. 19-22 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIGS. 19-22 may be modified according to FIGS. 1-9 above.



FIG. 23 is a view of an IVC filter having an improved echogenic characteristic. The filter 10 in FIG. 23 is made up of a set of seven wires. Six of these are approximately three inches in length when fully extended. The seventh is approximately two inches in length when fully extended. The wires are held together by two small sleeves or coils 12 and 14 of the same material, each coil being spot welded to hold it in place and approximately one-quarter of an inch in length; coil 12 is adjacent the tip 13 of the seven wires, and coil 14 is approximately two inches from tip 13 when the wires are fully extended. In the low temperature phase of the material the set of wires can be straightened and held in a straight form that can pass through a length of fine plastic tubing with an internal diameter of approximately 2 mm (#8 French catheter).


In its normal expanded configuration or performed filtering shape, filter 10 is a double filter, having a first filter basket 16 and a second filter basket 18. The two filter baskets provide peripheral portions which engage the inner wall of the vein at two longitudinally spaced locations. The two filter baskets are generally symmetrical about a longitudinal axis passing through filter tip 13.


The mesh of first filter basket 16 is formed from the sections of wires between the two quarter-inch coils 12 and 14. The mesh is made up of a series of seven overlapping loops 20 arranged to form a rosette approximately 25 mm in diameter. The loops are angled slightly relative to the long axis of filter 10 and this angle can be varied to accommodate somewhat smaller diameters if the device is to be constrained in a tube of less than 25 mm in caliber. The loops 20 effectively divide the cross-sectional area to be filtered. The rosette formed by loops 20 can expand or be compressed to fit various sizes of vein. The peripheral portions or tips of the loops 20 press outwardly against the inner wall of the vein, although without becoming imbedded in the vein; loops 20 thereby help to keep filter 10 in place. First filter basket 16 is convex relative to filter tip 13.


The mesh of second filter basket 18 is formed by the six circumferentially spaced free wire ends or legs 22, which tilt and bow outwardly of the long axis of filter 10. The seventh wire terminates within sleeve 14 for use in inserting filter 20. The six free ends or legs 22 that extend beyond the second quarter inch coil 14 diverge so that their tips form a circle 24 of approximately 40 mm in diameter at their maximum divergence. Each leg is also bowed outwardly slightly. The legs serve to orient the device relative to the long axis of the vena cava. Second filter basket 18 is convex relative to filter tip 13.


In another alternative embodiment the legs are tilted outwardly but are not formed with a bow. In such an embodiment, second filter basket 18 opens away from filter tip 13 without being strictly convex.


Each free end of leg 22 is bent sharply outward at about a right angle to form a hook 26 of approximately 1.5 mm in length. The hooks are intended to engage the wall of the vena cava to prevent migration proximally or distally.


The six legs 22 are of slightly different lengths to permit good packing within the delivery device, as will be described; if legs 22 are all of a single length, the hooks may interfere with one another, so that the filter does not expand properly when delivered into the vein.



FIG. 24 is a view of an IVC filter having an improved echogenic characteristic. In FIG. 16, a blood clot filter of the type intended for percutaneous introduction and delivery using a transfemoral approach is shown and is designated generally by reference numeral 20. Within FIG. 16, dashed lines 22 and 24 indicate the outline of an interior wall of a blood vessel, such as the inferior vena cava. Blood clot filter 20 consists essentially of a central core wire 26 which extends generally along the central longitudinal axis of blood clot filter 20, as well as six peripheral wires 28, 30, 32, 34, 36 and 38 spaced equiangularly about central core wire 26. Peripheral wires 36 and 38 are hidden from view in FIG. 16 by peripheral wires 30 and 32, respectively.


In FIG. 24, a first connector 40 is shown forming a nose of blood clot filter 20. Connector 40 serves to connect together a first end of each of peripheral wires 28-38, and attaches such peripheral wires about the first end of central core wire 26 at a first connection point. Connector 40 is welded, crimped or otherwise attached to the first end of central core wire 26 and to the first ends of peripheral wires 28-38 so that a fixed connection is achieved between the central core wire and the six peripheral wires.


Still referring to FIG. 24, the six peripheral wires 28-38 are again joined along their central portions by a second connector 42. Connector 42 is in the form of a tubular collar having a central opening defining an interior wall 44. Each of the peripheral wires 28-38 passes through tubular collar 42 and is secured to interior wall 44 thereof, as by welding or by other means of attachment. Thus, second connector 42 serves to connect together peripheral wires 28-38 at a second connection point spaced apart from the first connection point at first connector 40, it will be noted that central core wire 26 passes freely through the interior space defined by tubular collar 42 and the peripheral wire secured therein, thereby allowing second connector 42 to slide along central core wire 26.


The embodiment of the filter described above with regard to FIGS. 23 and 24 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIGS. 23 and 24 may be modified according to FIGS. 1-9 above.



FIG. 25 is a view of an IVC filter having an improved echogenic characteristic. The filter in FIG. 25 comprises four legs 1, 2, 3 and 4 diverging from an apical hub 5 at which the legs 1 to 4 are held together by an end ferrule 6 of the kind e.g. disclosed in U.S. Pat. No. 4,619,246, incorporated herein by reference.


Each leg comprises a central element 1a, 2a, 3a, and 4a bent into a smooth quasi-halfsinusoidal form and having a reversely turned anchoring hook 1b, 2b, 3b and 4b at its distal end with respect to hub 5 as well as two symmetrical curved side elements 1c, 2c, 3c and 4c, and 1d, 2d, 3d and 4d extending on either side of the central element.


In the embodiment shown the two side elements of each leg 1 to 4 are formed from one piece of wire the ends of which are held together in hub 5, whereas at the middle of its length the wire piece forms an eyelet 7, 8, 9 and 10 surrounding the central leg element to be freely slidable along a part of the length thereof.


From the unfolded tulip-like configuration illustrated in FIG. 25 the filter may be collapsed into a slender and very narrow bundle of filter elements the cross-sectional dimension of which is approximately equal to the sum of the thicknesses of the central and side elements of all four legs.


The side elements of each leg have a length and curvature such that in the unfolded tulip-like configuration of the filter the maximum distance between the side elements is of the same order as the distance between neighboring side elements of two adjacent legs. Moreover, the length and curvature is preferably chosen such that after insertion into the vena cava inferior the eyelets 7-10 will be positioned substantially at the inner side of the wall of the blood vessel.


As best seen in FIG. 25 the filter according to the invention has in its unfolded state a relatively short axial length of the same order as the diameter of the filter whereby proper arrangements of the filter into the inferior vena cava is facilitated.


The embodiment of the filter described above with regard to FIG. 25 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIG. 25 may be modified according to FIGS. 1-9 above.



FIG. 26 shows a filter generally designated by the numeral 12, and in FIG. 27 it is seen to comprise a generally dome-shaped body 14 of open work construction composed of skeletal members such as 16, 18, 20, 22, 24 and 26 which are arranged in a manner somewhat similar to the struts of an open umbrella canopy, and when in the open position shown in FIG. 27, span a distance d greater than that which characterizes the range of diameters commonly encountered in the inferior vena cava. In the preferred embodiment, the six radiating spokes are of collapsible, resilient, alloy material. The inward or converging proximal ends of the spokes or frame members con-verge to a hub 28 and are there united forming the skeletal frame. The distal ends of the struts or spokes all extend somewhat beyond the outer lip or margin of the canopy now to be described, and these ends are preferably sharpened to comprise a holding and gripping means, as will be apparent hereinafter. The canopy portion 30 comprises a suitable filter media of generally sheet form overlaying and being supported on the framework. Preferably, the filtering media includes a plurality of holes in the preferred embodiment, one hole being disposed in the generally triangular portion of the canopy between each of the spokes, and these holes or openings, one of which is designated by the numeral 32 for purposes of clarity, are on the order of about 3 millimeters in diameter and are circular in cross section. The pointed distal ends of the spokes appear as circumferential teeth which extend outwardly of the canopy. The hood or canopy is preferably of a flexible, smooth surfaced material, such as a plastic material, and which provides a smooth surface. For purposes-which will be apparent hereinafter, there is an axial recess 50 in the hub which is threaded.


The embodiment of the filter described above with regard to FIGS. 26 and 27 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIGS. 26 and 27 may be modified according to FIGS. 1-9 above.


With reference firstly to FIG. 28, there is thus illustrated a filter 1 in the unfolded position consisting of fingers 2, of which there are ten for example, which emerge from a head 3 and which can be unfolded substantially in a generally conical shape of which the opening is marked in dashed lines at 4. Each finger is provided at its free end with a centering and bearing runner 5 which turns substantially behind the head 3; that is, this runner 5 is directed from the end 2a of the fingers towards the closure side of the cone forming the filter. More precisely, if we designate as 6 the cylinder generated by a generating line that is parallel with the axis 7 of the conical shape formed by the filter 1 and moved such that it describes the line 4, the runners 5 are directed such that they are substantially parallel with the wall of the cylinder 6.


In accordance with the invention, the filter fingers consist of flexible wires 8. They may in particular consist of metal wires, for example of a suitable grade of stainless steel. The diameter of the wires may be between 2 and 4 tenths of a millimeter for example 3 or 3.5 tenths of a millimeter.


These fingers are combined in groups of two adjacent fingers by a wire part which is folded in the manner of a hairpin 9 and forms said runners. As a result, the fingers are in the general shape of a clip 10. Advantageously, the filter preferably comprises at least six of the above fingers connected to three wire portions folded in the manner of a pin and distributed in an angular manner so as to ensure that the filter has good axial stability.


Referring to FIG. 29, it will be noted that the filter, which is generally indicated 1, comprises a series of elongated branches or legs 3 each of which is substantially “V”-shaped. One of the free ends of each “V” comprises fixation means such as a hook 5 for anchoring the filter to the vessel wall. The other end is connected to a metal thread, which has a succession of corrugations or undulations (such as zig-zags) forming a resilient annular structure 7 of which the central opening has a diameter which can be more or less “constricted” and which is adapted to permit the passage of the temporary filter. The various branches 3 can be produced in the form of fine metal threads and are secured around the annular structure or ring 7 However, the whole of the filter could also be produced in a single metal piece, its structure being obtained by cutting.


In order to be introduced into the vessel, the filter 1 can adopt a constrained state in which the elongated branches or legs 3 are moved close up to the axis 18 of the central opening of the filter until they are substantially parallel thereto. When it is in place in the vessel, the filter adopts a radially expanded state, the branches 3 then moving away from the axis 18 and the hooks 5 anchoring themselves in the vessel wall.


The embodiment of the filter described above with regard to FIGS. 28 and 29 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIGS. 28 and 29 may be modified according to FIGS. 1-9 above.


In FIG. 30 there is illustrated a vena cava filter comprising a filter basket generally designated by 1 and consisting of a plurality of thin resilient wires 2 of a suitable material, preferably a stainless steel alloy. As illustrated in FIG. 30, basket 1 is generally shaped as an elongate, apertured solid of revolution resulting from the rotation of a sinusoid curve about an axis of rotation indicated in FIG. 30 by a dot-and-dash-line 3, which is tangent to the generatrix at the ends thereof. At each end of the basket proper, the wires are interconnected by means of a short ferrule 4 secured to the wires by any appropriate means, such as brazing.


As shown in FIG. 30 the ratio of the basket length to its maximum diameter is approximately 2. It should be understood that the exact value of this ratio is not critical for the function of the filter basket and in practice it may assume a value between 1.5 and 3, or even higher, although probably the improvement at higher values may be marginal.


As appears from FIG. 30, between the end ferrules 4 each wire 2 follows a helix-like curve, all curves being similar and having the same “hand”, in the example right-handed. From one end to the other, each wire 2 is “twisted” approximately 90° about the axis 3.


In FIG. 30 a small, oblong eyelet 5 of wire similar to wires 2 is secured in each ferrule 4 so as to protrude axially from basket 1. By means of either eyelet 5 and a mating hook or other gripping device at the end of an insertion wire, the collapsed filter basket may be pushed or pulled through an inserting catheter, as briefly discussed above.


A plurality of anchoring legs 6, in the example five, are secured in the right-hand ferrule 4 of FIG. 30, from which they extend axially away from basket 1 and outwardly relative to axis 3. The free end of each leg 6 is bent outwardly to form a hook 7 which, when the filter basket has been positioned in a blood vessel, penetrates slightly into the wall of the vessel so as to hold the filter basket in position. Legs 6 will normally be made of the same or a similar material as wires 2 so that they can be readily collapsed to fit within the lumen of the insertion catheter, and spring back to engage the wall of the blood vessel when released from the catheter. The pronounced S-shape of legs 6 in the region immediately inwardly of hooks 7 ensures that when the filter basket moves through the catheter it will be the smooth curved portions of the legs rather than the hooks 7 which contact the catheter wall.


The embodiment of the filter described above with regard to FIG. 30 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIG. 30 may be modified according to FIGS. 1-9 above.


Referring now to the drawings, FIG. 31 shows the filter 1 of the present invention which firstly comprises filtering section 2 adapted to open out in the blood vessel 3, particularly the inferior vena cava, when the filter is correctly positioned in the patient.


These filtering section 2 are advantageously constituted by an assembly of flexible filiform elements 4 joined together by one of their ends to form substantially the envelope of a cone, ogive or the like.


In this way, this assembly of filiform filtering elements 4 will be permeable to the blood flow, indicated by arrows 5, but adapted to retain the clots. To that end, it will be disposed in the direction of the blood flow, i.e. the apex of the cone or the like will be directed substantially in the same direction as the blood flow.


By way of example, the flexible rods 4 will be six in number and made of a biocompatible material, such as a suitable metal alloy or plastics material. However, these materials will be chosen for their aptitude to elasticity and to deformation.


In fact, the rods 4 will represent a good flexibility in order, on the one hand, to be folded in a catheter of small dimensions and, on the other hand, to open out correctly in the blood vessel to form a barrage at the latter's dimensions.


Furthermore, the filiform filtering elements 4 will be such that they are non-aggressive with respect to the inner walls of the vessel.


More precisely, as shown in FIG. 31, the rods 4 present at least a slight angle or curve 6, so that their terminal part 7 is in non-aggressive contact with the vessel, when the filtering means are opened out, but so that there is no penetration of the ends of the rods 4 in the wall of the vessel proper.


The embodiment of the filter described above with regard to FIG. 23 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIG. 23 may be modified according to FIGS. 1-9 above.


Referring now to the drawings, and firstly to FIG. 32, a filter device (hereinafter referred to as “filter”) according to the present invention is essentially constituted by an assembly of identical, curved, elastic legs 1, for example six in number, disposed in two's successively in opposite direction, and joined together at their ends 2, 3, particularly by fixing them, for example by electrical spot welding, on two connecting pieces 4, 5.


Each connecting piece is constituted by a substantially cylindrical, hollow piece, the connecting pieces 4 and 5 presenting different internal diameters.


Legs 1, in the out-spread state for use, are angularly distributed in substantially regular manner, for example spaced apart successively in two's by about 60°.


Each leg 1 comprises a convex portion, whose apex 6 is adapted to abut against the inner wall of the vein 7 when the legs are in out-spread state for use.


This convex portion, which may for example be made by burnishing, is closer to one end of leg 1 than the other, with the result that, the legs being identical and mounted successively in two's in opposite direction, said filter abuts on the vein, at the level of apices 6, via two series of points spaced apart longitudinally by a predetermined distance.


The embodiment of the filter described above with regard to FIG. 32 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIG. 32 may be modified according to FIGS. 1-9 above.


As shown in FIG. 33, the embolus trap comprises a central cylindrical column 11 to which is attached a plurality of upper elongated loops 12 of filaments 13 and 14, such as metal wire, and a plurality of like lower loops 15. Loops 12 and 15 are assembled in two tiers spaced from one another on column 11. The loops 12 in the upper tier are circumferentially spaced from each other in symmetrical fashion, as are the loops 15 in the lower tier. The loops of adjacent tiers are displaced from each other circumferentially, preferably centrally, so that a loop 12 of the upper tier is centrally located between two loops 15 of the lower tier, and vice versa. The inner ends of adjoining filaments, such as 13 and 14, are anchored in central column 11 and the outer ends of those filaments are joined or abutted to form a closed elongated loop. The outer ends of filaments 13 and 14 are bent toward each other to form short circumferentially extending portions 18 and 19 respectively, and then 180° in the same plane to form oppositely extending circumferential portions 20 and 21 respectively. The extreme ends of portions 20 and 21 are bent radially outwardly into hooks 22. The wires of each loop may be joined at the crowns of the open loops formed by bent portions 18 and 20 of wire 13 and 19 and 21 of wire 14, as by tying the wires over the loops. Those circumferentially bent portions 20 and 21 form a stop or barrier which prevents hooks 22 from penetrating the wall 24 of the passageway 10 sufficient to puncture it.


As shown in FIG. 33, The filaments in each tier are positioned in pairs at the desired spacing around column 11, enclosed in a metal sleeve 50, and are welded thereto at an end of the sleeve. The sleeve 50 with filaments attached is then crimped on column 11. Column 11 is hollow, and preferably rigid, having a central cavity 51 running therethrough.


The embodiment of the filter described above with regard to FIG. 33 may be modified to be a filter having enhanced echogenic properties characteristics or features. This filter embodiment may be modified with enhanced echogenic characteristics including one or more than one of: (a) a modification to one or more components of the filter to enhance the echogenic characteristics of the component; (b) formation of dimples into a component surface of sufficient number and scaled to a suitable size, shape, orientation and pattern for use with intravascular ultrasound systems; (c) protrusions formed in, placed on or joined to a filter surface; (d) roughening one or more surfaces of a filter, for example using a chemical process, a laser or bead blasting technique; and (e) altering one or more steps of a filter manufacturing technique to introduce cavities, voids or pockets to locally modify or adapt one or more acoustic reflection characteristics to improve echogenicity in one or more specific regions of a filter. In other aspects, the filter illustrated and described in FIG. 33 may be modified according to FIGS. 1-9 above.


In some aspects, any of the above described filters may be modified to include hybrid or dual mode features. One example of a dual mode feature is one that is both radio opaque and also echogenic. In still another aspect, the above described filters may also include a material capture structure as described below, with or without one or more imaging modes as described herein.


In still other alternative embodiments, there is provided a material capture structure having one or more echogenic enhancements alone or in combination with radiopaque enhancements. In one aspect, the filter structure used in a filter includes both echogenic and radio opaque enhancements.


An one aspect, the filter includes material capture structure in the IVC filter will be viewable under fluoroscopic and ultrasound imaging modalities, including appropriate echogenic characteristics to enhance the view of the status or condition of the material capture structure while using IVUS. Enabling the material capture structure to be viewed will allow the physician to appropriately center and verify placement of a filter.


In one aspect, the filter elements or structures are doped to incorporate one or more of echogenic or radio opaque materials or treatments. In one aspect, the filaments or strands or other structures used to form the filter structure or webbing of the filter includes a radiopaque material having high echogenic properties, such as tungsten or gold, but not limited to either.


In other embodiments, one or more filaments or portions of a filament within a material capture structure includes one or more non-metallic echogenic features, such as those described elsewhere in this specification. For example, a filament or portion thereof may include air pockets either added to the material or by the use of materials with entrained air or gas that are used. In one embodiment, an ePTFE suture has echogenic properties due to air content of the ePTFE material. In other aspects, a suture material or a filament or polymer strand may also include dimpled/roughened/matrix/sponge materials, additives, or modifications to provide or enhance the overall echogenic nature of the suture, filament, material or material capture structure, in whole or in part.


In one aspect, these additional materials may assist the physician in centering or placing a filter within a vessel. In another aspect, this improvement is used in conjunction with IVUS will enable the adequate viewing of the filter portion of the filter and will allow for co-registration of filter placement along with an accurate entry/removal of the catheter through the webbing of the filter.


The advantages of this inventive aspect of a filter include, for example and not limitation, filter placement, accurate representation of filter location, ease of introducing/retracting catheter, more viewable space for more accurate assessments, ability to co-register filter location with IVUS and/or ability to better place filter in desired location.


Still other aspects of the use of the innovative filter include, for example, deployment of filters, positioning of filters, sizing of filters, and estimated treatment lengths as well as suture and/or material capture structure visibility. In still other aspects of the use of the innovative filter include, for example, deployment of a vena cava filter, positioning of an IVC filter, sizing of an IVC filter, and estimated treatment lengths as well as enhanced suture visibility.


In one embodiment, there is an IVC filter delivery system with an enclosed IVC filter. This filter would have a mesh, suture, web or other material capture structure suited to the anticipated filter use. The mesh, suture, web or other material capture structure has one or more components that is doped with a highly radiopaque material for better visibility under flouro and good echogenicity for better viewing under IVUS guidance. In still further alternative embodiments, the techniques described above may be applied to one or more material capture structure described in U.S. Patent Application Publication No. US 2008/0147111 entitled “Endoluminal Filter with Fixation” filed Jun. 4, 2008 as U.S. patent application Ser. No. 11/969,827, (the “'7111 publication”) incorporated herein by reference in its entirety for all purposes. More particularly, the aspects of modifying a material capture structure to exhibit radio opaque, echogenic of combinations of radio opaque and echogenic characteristics may be applied to the various embodiments illustrated and described in FIGS. 30-34B, 38A-38B, 39-67, and 83-87. In one particular aspect, the filament/strand/suture 461 shown in FIG. 58 of the '7111 publication may be coated or doped as described above alone or in combination with the illustrated pharmacological coating 466.


In still another alternative aspect, any of the material capture structures in the '7111 publication may be combined with any of the filters illustrated and described in FIGS. 9-33. The material capture structures may be joined to the wires or other supports in the filters described herein to provide additional kinds of filtering capabilities in addition to or in place of the filtering capabilities of the filter so described.


In some embodiments, a pressure sensor and/or an intravascular ultrasound (IVUS) transducer can be added to or incorporated into a delivery system and method for use with any of the filters described herein. The pressure sensor can be used to measure the pressure at various positions within the vasculature, which can be used to determine blood flow, while the intravascular ultrasound (IVUS) transducer can be used to measure fluid flow and/or provide imaging within the vessel. These activities can be performed in cooperation with any of the filter embodiments described herein. In some embodiments, the pressure sensor and/or IVUS transducer can be incorporated into the guidewire at one or more locations, such as the distal end or distal portion of a guidewire, as described in U.S. Pat. Nos. 8,277,386, 6,106,476 and 6,780,157 which are hereby incorporated by reference in their entireties for all purposes, as well as being incorporated into intermediate and proximal portions of the guidewire. The guidewire with the pressure sensor and/or the IVUS transducer can be used much like a normal guidewire to help navigate the delivery device through the vasculature, with the added benefit of providing pressure measurements and ultrasound imaging to help in the navigation, to visualize the device placement site, and to monitor and ensure proper device deployment. In some embodiments, the IVUS transducer generates image slices as it is advanced and retracted which can then be assembled together to form a three dimensional reconstruction of the vasculature and/or the device within the vasculature. In some embodiments, the guidewire with the pressure sensor and/or IVUS transducer can be fastened to a catheter in a similar manner to that described below for a catheter having a pressure sensor and/or IVUS transducer that is fastened to another catheter.



FIGS. 34A-34C illustrate an example of a guidewire X100 having both a pressure sensor X102 and an IVUS transducer X104 located at the distal portion of the guidewire X100. In some embodiments, the pressure sensor X102 can be made from a semiconductor material, such as silicon, that is formed into a diaphragm and can be located proximally of the distal tip, while the IVUS transducer X104 can be located at the distal tip of the guidewire X104.


In some embodiments, the pressure sensor and/or IVUS transducer can be located on a catheter in a similar configuration to the guidewire. For example, the IVUS transducer can be located on the distal tip of the catheter while the pressure sensor(s) can be located proximally of the IVUS transducer at one or more locations along the catheter body, from the distal portion of the catheter to an intermediate portion of the catheter to the proximal portion of the catheter. The pressure and/or imaging catheter can be used in parallel with the delivery or retrieval device or any other catheter that is inserted into the vasculature. In some embodiments, the pressure and/or imaging catheter can be fastened to the delivery or retrieval device or other catheter by, for example, enclosing both catheters in a sheath or larger catheter or by fusing the two catheters together. For example, U.S. Pat. Nos. 6,645,152 and 6,440,077, both to Jung et al. and hereby incorporated by reference in their entireties for all purposes, discloses an intravascular ultrasound catheter joined together in parallel with a vena cava filter delivery device to guide placement of the filter in the vena cava. The pressure and/or imaging catheter can be used for the same purposes as the pressure and/or imaging guidewire.



FIGS. 35A-35D illustrate two embodiments of an intravascular ultrasound catheter X200 joined together in parallel with a catheter X202 that can be used, for example, to deliver a device to a location with the vasculature, such as a vena cava filter to the vena cava. The intravascular ultrasound catheter X200 can have an IVUS transducer X204 located on the distal portion of the IVUS catheter X200. The IVUS transducer X204 can be a solid state transducer that is disk shaped or cylindrically shaped with a hole to allow passage of a guidewire X206 or other device through the IVUS catheter X200. As shown in FIGS. 35A and 35B, the IVUS catheter X200 and the delivery catheter X202 can be joined together in parallel without a sheath by adhering or fusing the two catheters together. FIGS. 35C and 35D illustrate the same IVUS catheter X200 and delivery catheter X202 fastened together using a sheath X208.


In some embodiments as illustrated in FIGS. 36A and 36B, the pressure sensor and/or IVUS transducer can be integrated into the delivery or retrieval catheter X300 or device itself. In one aspect, the device is any of the filters having enhanced capabilities described herein. For example, the IVUS transducer X302 can be integrated into the distal tip or end of the catheter X300 or device. The pressure sensor X304 can be located on a distal portion of the catheter shaft proximally of the IVUS transducer X302. A wire can extend from the IVUS transducer X302 and/or pressure sensor X304 to one or more connectors X306 located at the proximal end of the catheter X300. The connector(s) X306 can be used to connect the IVUS transducer X302 and/or pressure sensor X304 to an imaging system and/or processing system. In the illustrated embodiment, the catheter X300 can be used to deliver a vena cava filter X308 to the vena cava. The catheter X300 can additionally have a telescoping sleeve or pusher rod to deploy the vena cava filter X308, or alternatively, the outer catheter sheath can be retracted to deployed the filter. The IVUS transducer can provide positioning guidance and determine the relative location of the filter by advancing and retracting the IVUS transducer X302 on the catheter X300 to generate a plurality of image slices that can be assembled to reconstruct a three dimensional image.


Use of the ultrasound imaging system allows the operator to deliver the device without fluoroscopy or using less fluoroscopy, thereby reducing the radiation exposure to the patient, while allowing more accurate evaluation of the vasculature, aiding placement of the device and allowing confirmation that device placement was proper. The imaging can be used to aid in the deployment of the filters or other devices. The vasculature and implant location can be imaged prior to deployment, after deployment and/or during deployment. The imaging can be used to aid in positioning of the filter or device within the vasculature. The imaging can be used to image the deployment location and determine the appropriate sizing of the filter or other device. The imaging can be used to help estimate treatment duration.


Although an imaging systems described above have been ultrasound based, other imaging systems can be used instead or in addition. For example, the imaging system can be based on intravascular ultrasound (IVUS), Forward-Looking IVUS (FLIVUS), optical coherence tomography (OCT), piezoelectric micro-machined ultrasound traducer (PMUT), and FACT.


Additional aspects of the formation and use of echogenic materials is made with reference to the following US Patents and Patent Publications, each of which is incorporated herein by reference in its entirety: US 2010/0130963; U.S. Pat. Nos. 5,921,933; 4,276,885; 4,572,203; 4,718,433; 4,442,843; 5,327,891; 4,401,124; 4,265,251; 4,466,442; 4,718,433; 5,081,997; 5,289,831; and 5,201,314. Additional details of various filter designs described herein may be obtained with reference to the following U.S. Pat. Nos. 3,952,747; 4.817,600; 5,059,205; 5,242,462; 6,620,183; 6,217,600; 8,273,099; 4,494,531; 4,425,908; 4,832,055; 5,133,733; 3,540,431; 5,344,427; 5,725,550; 4,619,246; 4,990,156; 5,234,458; and 4,643,184, each of which is incorporated herein by reference in its entirety.

Claims
  • 1. A filter comprising: a hub; anda plurality of legs or wires or segments extending from the hub; wherein the plurality of legs or wires or segments comprise a first section having a first pattern of voids formed therein to provide an enhanced echogenic characteristic of the first section and a second section having a second pattern of voids formed therein to provide an enhanced echogenic characteristic of the second section, wherein the first pattern of voids is different than the second pattern of voids.
  • 2. The filter of claim 1 wherein the first pattern of voids is filled with air.
  • 3. The filter of claim 2 wherein the second pattern of voids is filled with air.
  • 4. The filter of claim 2 wherein the second pattern of voids is filled with an echogenic material.
  • 5. The filter of claim 1 wherein the first pattern of voids is filled with an echogenic material.
  • 6. The filter of claim 1 wherein the first pattern of voids are air bubbles formed within the first section.
  • 7. The filter of claim 1 wherein the first pattern of voids are air bubbles formed within an ePTFE material forming the first section of the portion of one or more of the legs or wires or segments.
  • 8. The filter of claim 1 wherein the first pattern of voids is scaled to a suitable size, shape and orientation for use with an intravascular ultrasound system.
  • 9. The filter of claim 1 further comprising at least one fixation element and wherein the fixation element comprises a third pattern of voids to provide an enhanced echogenic characteristic of the at least one fixation element or the filter.
  • 10. A filter comprising: a hub; anda plurality of segments extending from the hub, wherein a first of the plurality of segments comprises a first pattern of voids formed therein to provide an enhanced echogenic characteristic of the first of the plurality of segments, wherein a second of the plurality of segments comprises a second pattern of voids formed therein to provide an enhanced echogenic characteristic of the second of the plurality of segments, wherein the first pattern is different than the second pattern.
  • 11. The filter of claim 10 wherein the first pattern of voids comprise an air gap formed in the first segment.
  • 12. The filter of claim 11 wherein the second pattern of voids comprises an air gap formed in the second segment.
  • 13. The filter of claim 11 wherein the second pattern of voids is filled with an echogenic material.
  • 14. The filter of claim 10 wherein the first pattern of voids comprise a gap formed in the first segment, wherein the gap is filled with an echogenic material.
  • 15. The filter of claim 10 wherein the first pattern of voids comprises an air pocket in an ePTFE material.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Patent Application No. 61/785,204, filed Mar. 14, 2014, which is herein incorporated by reference in its entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2014/027259 3/14/2014 WO 00
Publishing Document Publishing Date Country Kind
WO2014/152365 9/25/2014 WO A
US Referenced Citations (1079)
Number Name Date Kind
152652 Knowlton Jun 1874 A
407971 Siersdorfer Jul 1889 A
621937 Niemann Mar 1899 A
796910 Hernan Aug 1905 A
1950378 Andrews Mar 1934 A
2163324 Reinhold Jun 1939 A
3301258 Werner Jan 1967 A
3540431 Megin-Uddin Nov 1970 A
3617880 Cormack et al. Nov 1971 A
3789841 Antoshkiw Feb 1974 A
3841308 Tate Oct 1974 A
3952747 Kimmell Apr 1976 A
4140364 Yamashita et al. Feb 1979 A
4265251 Tickner May 1981 A
4274423 Mizuno et al. Jun 1981 A
4276885 Tickner et al. Jul 1981 A
4344438 Schultz Aug 1982 A
4398791 Dorsey Aug 1983 A
4401124 Guess et al. Aug 1983 A
4425908 Simon Jan 1984 A
4432370 Hughes et al. Feb 1984 A
4442843 Rasor et al. Apr 1984 A
4466442 Hilmann et al. Aug 1984 A
4494531 Gianturco Jan 1985 A
4552554 Gould et al. Nov 1985 A
4572203 Feinstein Feb 1986 A
4577543 Wilson Mar 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4676980 Segal et al. Jun 1987 A
4682895 Costello Jul 1987 A
4718433 Feinstein Jan 1988 A
4733665 Palmaz Mar 1988 A
4744619 Cameron May 1988 A
4762129 Bonzel Aug 1988 A
4766386 Oliver et al. Aug 1988 A
4771774 Simpson et al. Sep 1988 A
4794931 Yock Jan 1989 A
4800886 Nestor Jan 1989 A
4803639 Steele et al. Feb 1989 A
4816567 Cabilly et al. Mar 1989 A
4817600 Herms et al. Apr 1989 A
4819740 Warrington Apr 1989 A
4821731 Martinelli et al. Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4830023 de Toledo et al. May 1989 A
4832055 Palestrant May 1989 A
4834093 Littleford et al. May 1989 A
4841977 Griffith et al. Jun 1989 A
4864578 Proffitt et al. Sep 1989 A
4873690 Adams Oct 1989 A
4877314 Kanamori Oct 1989 A
4887606 Yock et al. Dec 1989 A
4917085 Smith Apr 1990 A
4917097 Proudian et al. Apr 1990 A
4928693 Goodin et al. May 1990 A
4932413 Shockey et al. Jun 1990 A
4932419 de Toledo Jun 1990 A
4948229 Soref Aug 1990 A
4951677 Crowley et al. Aug 1990 A
4969742 Falk et al. Nov 1990 A
4987412 Vaitekunas et al. Jan 1991 A
4990156 Lefebvre Feb 1991 A
4993412 Murphy-Chutorian Feb 1991 A
4998972 Chin et al. Mar 1991 A
5000185 Yock Mar 1991 A
5024234 Leary et al. Jun 1991 A
5025445 Anderson et al. Jun 1991 A
5032123 Katz et al. Jul 1991 A
5037169 Chun Aug 1991 A
5039193 Snow et al. Aug 1991 A
5040548 Yock Aug 1991 A
5041108 Fox et al. Aug 1991 A
5054492 Scribner et al. Oct 1991 A
5059205 El-Nounou et al. Oct 1991 A
5065010 Knute Nov 1991 A
5065769 de Toledo Nov 1991 A
5081997 Bosley et al. Jan 1992 A
5085221 Ingebrigtsen et al. Feb 1992 A
5095911 Pomeranz Mar 1992 A
5098440 Hillstead Mar 1992 A
5100424 Jang et al. Mar 1992 A
5120308 Hess Jun 1992 A
5125137 Corl et al. Jun 1992 A
5133733 Rasmussen et al. Jul 1992 A
5135486 Eberle et al. Aug 1992 A
5135516 Sahatjian et al. Aug 1992 A
5155439 Holmbo et al. Oct 1992 A
5158548 Lau et al. Oct 1992 A
5163445 Christian et al. Nov 1992 A
5167233 Eberle et al. Dec 1992 A
5174295 Christian et al. Dec 1992 A
5176141 Bom et al. Jan 1993 A
5176674 Hofmann Jan 1993 A
5178159 Christian Jan 1993 A
5183048 Eberle Feb 1993 A
5188632 Goldenberg Feb 1993 A
5201314 Bosley et al. Apr 1993 A
5201316 Pomeranz et al. Apr 1993 A
5202745 Sorin et al. Apr 1993 A
5203779 Muller et al. Apr 1993 A
5220922 Barany Jun 1993 A
5224953 Morgentaler Jul 1993 A
5226421 Frisbie et al. Jul 1993 A
5234458 Metais Aug 1993 A
5240003 Lancee et al. Aug 1993 A
5240437 Christian Aug 1993 A
5242460 Klein et al. Sep 1993 A
5242462 El-Nounou et al. Sep 1993 A
5243988 Sieben et al. Sep 1993 A
5257974 Cox Nov 1993 A
5266302 Peyman et al. Nov 1993 A
5267954 Nita Dec 1993 A
5289831 Bosley Mar 1994 A
5301001 Murphy et al. Apr 1994 A
5312425 Evans et al. May 1994 A
5313949 Yock May 1994 A
5313957 Little May 1994 A
5319492 Dorn et al. Jun 1994 A
5321501 Swanson et al. Jun 1994 A
5325198 Hartley et al. Jun 1994 A
5327891 Rammier Jul 1994 A
5336178 Kaplan et al. Aug 1994 A
5344427 Cottenceau et al. Sep 1994 A
5346689 Peyman et al. Sep 1994 A
5348017 Thornton et al. Sep 1994 A
5348481 Ortiz Sep 1994 A
5353798 Sieben Oct 1994 A
5358409 Obara Oct 1994 A
5358478 Thompson et al. Oct 1994 A
5368037 Eberle et al. Nov 1994 A
5370657 Irie Dec 1994 A
5373845 Gardineer et al. Dec 1994 A
5373849 Maroney et al. Dec 1994 A
5375602 Lancee et al. Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5377682 Ueno et al. Jan 1995 A
5383853 Jung et al. Jan 1995 A
5387193 Miraki Feb 1995 A
5396328 Jestel et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5411016 Kume et al. May 1995 A
5419777 Hofling May 1995 A
5421338 Crowley et al. Jun 1995 A
5423806 Dale et al. Jun 1995 A
5427118 Nita et al. Jun 1995 A
5431673 Summers et al. Jul 1995 A
5436759 Dijaili et al. Jul 1995 A
5439139 Brovelli Aug 1995 A
5443457 Ginn et al. Aug 1995 A
5453575 O'Donnell et al. Sep 1995 A
5456693 Conston et al. Oct 1995 A
5459570 Swanson et al. Oct 1995 A
5480388 Zadini et al. Jan 1996 A
5485845 Verdonk et al. Jan 1996 A
5492125 Kim et al. Feb 1996 A
5496997 Pope Mar 1996 A
5507761 Duer Apr 1996 A
5512044 Duer Apr 1996 A
5514128 Hillsman et al. May 1996 A
5529674 Hedgcoth Jun 1996 A
5541730 Chaney Jul 1996 A
5546717 Penczak et al. Aug 1996 A
5546948 Hamm et al. Aug 1996 A
5565332 Hoogenboom et al. Oct 1996 A
5573520 Schwartz et al. Nov 1996 A
5581638 Givens et al. Dec 1996 A
5586054 Jensen et al. Dec 1996 A
5592939 Martinelli Jan 1997 A
5596079 Smith et al. Jan 1997 A
5598844 Diaz et al. Feb 1997 A
5601595 Smith Feb 1997 A
5609606 O'Boyle Mar 1997 A
5626605 Irie et al. May 1997 A
5630806 Inagaki et al. May 1997 A
5651366 Liang et al. Jul 1997 A
5660180 Malinowski et al. Aug 1997 A
5667499 Welch et al. Sep 1997 A
5667521 Keown Sep 1997 A
5672877 Liebig et al. Sep 1997 A
5674232 Halliburton Oct 1997 A
5693015 Walker et al. Dec 1997 A
5713848 Dubrul et al. Feb 1998 A
5725550 Nadal Mar 1998 A
5725552 Kotula et al. Mar 1998 A
5745634 Garrett et al. Apr 1998 A
5771895 Slager Jun 1998 A
5779731 Leavitt Jul 1998 A
5780958 Strugach et al. Jul 1998 A
5798521 Froggatt Aug 1998 A
5800450 Lary et al. Sep 1998 A
5803083 Buck et al. Sep 1998 A
5814061 Osborne et al. Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5817025 Alekseev et al. Oct 1998 A
5820594 Fontirroche et al. Oct 1998 A
5824520 Mulligan-Kehoe Oct 1998 A
5827313 Ream Oct 1998 A
5830222 Makower Nov 1998 A
5848121 Gupta et al. Dec 1998 A
5851464 Davila et al. Dec 1998 A
5857974 Eberle et al. Jan 1999 A
5872829 Wischmann et al. Feb 1999 A
5873835 Hastings et al. Feb 1999 A
5882722 Kydd Mar 1999 A
5912764 Togino Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5921931 O'Donnell et al. Jul 1999 A
5921933 Sarkis et al. Jul 1999 A
5925055 Adrian et al. Jul 1999 A
5925060 Forber Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5949929 Hamm Sep 1999 A
5951586 Berg et al. Sep 1999 A
5974521 Akerib Oct 1999 A
5976120 Chow et al. Nov 1999 A
5978391 Das et al. Nov 1999 A
5997523 Jang Dec 1999 A
6021240 Murphy et al. Feb 2000 A
6022319 Willard et al. Feb 2000 A
6031071 Mandeville et al. Feb 2000 A
6036889 Kydd Mar 2000 A
6043883 Leckel et al. Mar 2000 A
6050949 White et al. Apr 2000 A
6053925 Barnhart Apr 2000 A
6059738 Stoltze et al. May 2000 A
6068638 Makower May 2000 A
6074362 Jang et al. Jun 2000 A
6078831 Belef et al. Jun 2000 A
6080109 Baker et al. Jun 2000 A
6080178 Meglin Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6091496 Hill Jul 2000 A
6094591 Foltz et al. Jul 2000 A
6095976 Nachtomy et al. Aug 2000 A
6097755 Guenther, Jr. et al. Aug 2000 A
6099471 Torp et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6102938 Evans et al. Aug 2000 A
6106476 Corl et al. Aug 2000 A
6120445 Grunwald Sep 2000 A
6123673 Eberle et al. Sep 2000 A
6134003 Tearney et al. Oct 2000 A
6139510 Palermo Oct 2000 A
6141089 Thoma et al. Oct 2000 A
6146328 Chiao et al. Nov 2000 A
6148095 Prause et al. Nov 2000 A
6151433 Dower et al. Nov 2000 A
6152877 Masters Nov 2000 A
6152878 Nachtomy et al. Nov 2000 A
6159225 Makower Dec 2000 A
6160084 Langer et al. Dec 2000 A
6165127 Crowley Dec 2000 A
6176842 Tachibana et al. Jan 2001 B1
6179809 Khairkhahan et al. Jan 2001 B1
6186949 Hatfield et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6200266 Shokrollahi et al. Mar 2001 B1
6200268 Vince et al. Mar 2001 B1
6203537 Adrian Mar 2001 B1
6208415 De Boer et al. Mar 2001 B1
6210332 Chiao et al. Apr 2001 B1
6210339 Kiepen et al. Apr 2001 B1
6212308 Donald Apr 2001 B1
6217600 Dimatteo Apr 2001 B1
6231518 Grabek et al. May 2001 B1
6245066 Morgan et al. Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6254543 Grunwald et al. Jul 2001 B1
6256090 Chen et al. Jul 2001 B1
6258026 Ravenscroft et al. Jul 2001 B1
6258052 Milo Jul 2001 B1
6261246 Pantages et al. Jul 2001 B1
6275628 Jones et al. Aug 2001 B1
6283921 Nix et al. Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6295308 Zah Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6312384 Chiao Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328696 Fraser Dec 2001 B1
6343168 Murphy et al. Jan 2002 B1
6343178 Burns et al. Jan 2002 B1
6350240 Song et al. Feb 2002 B1
6364841 White et al. Apr 2002 B1
6366722 Murphy et al. Apr 2002 B1
6367984 Stephenson et al. Apr 2002 B1
6373970 Dong et al. Apr 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6375618 Chiao et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6376830 Froggatt et al. Apr 2002 B1
6379352 Reynolds et al. Apr 2002 B1
6381350 Klingensmith et al. Apr 2002 B1
6387124 Buscemi et al. May 2002 B1
6388043 Langer et al. May 2002 B1
6396976 Little et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6417948 Chowdhury et al. Jul 2002 B1
6419644 White et al. Jul 2002 B1
6421164 Tearney et al. Jul 2002 B2
6423012 Kato et al. Jul 2002 B1
6426796 Pulliam et al. Jul 2002 B1
6428041 Wohllebe et al. Aug 2002 B1
6428498 Uflacker Aug 2002 B2
6429421 Meller et al. Aug 2002 B1
6440077 Jung et al. Aug 2002 B1
6443903 White et al. Sep 2002 B1
6443972 Bosma et al. Sep 2002 B1
6450964 Webler Sep 2002 B1
6457365 Stephens et al. Oct 2002 B1
6459844 Pan Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6475149 Sumanaweera Nov 2002 B1
6480285 Hill Nov 2002 B1
6491631 Chiao et al. Dec 2002 B2
6491636 Chenal et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6504286 Porat et al. Jan 2003 B1
6508824 Flaherty et al. Jan 2003 B1
6514237 Maseda Feb 2003 B1
6514273 Voss et al. Feb 2003 B1
6520269 Geiger et al. Feb 2003 B2
6520677 Iizuka Feb 2003 B2
6535764 Imran et al. Mar 2003 B2
6538778 Leckel et al. Mar 2003 B1
6544217 Gulachenski Apr 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6544279 Hopkins et al. Apr 2003 B1
6545760 Froggatt et al. Apr 2003 B1
6546272 MacKinnon et al. Apr 2003 B1
6551250 Khalil Apr 2003 B2
6566648 Froggatt May 2003 B1
6570894 Anderson May 2003 B2
6572555 White et al. Jun 2003 B2
6579311 Makower Jun 2003 B1
6584335 Haar et al. Jun 2003 B1
6592612 Samson et al. Jul 2003 B1
6594448 Herman et al. Jul 2003 B2
6602241 Makower et al. Aug 2003 B2
6611322 Nakayama et al. Aug 2003 B1
6611720 Hata et al. Aug 2003 B2
6612992 Hossack et al. Sep 2003 B1
6615062 Ryan et al. Sep 2003 B2
6615072 Izatt et al. Sep 2003 B1
6620183 Dimatteo Sep 2003 B2
6621562 Durston Sep 2003 B2
6631284 Nutt et al. Oct 2003 B2
6638227 Bae Oct 2003 B2
6645152 Jung et al. Nov 2003 B1
6646745 Verma et al. Nov 2003 B2
6655386 Makower et al. Dec 2003 B1
6659957 Vardi et al. Dec 2003 B1
6660024 Flaherty et al. Dec 2003 B1
6663565 Kawagishi et al. Dec 2003 B2
6665456 Dave et al. Dec 2003 B2
6669716 Gilson et al. Dec 2003 B1
6671055 Wavering et al. Dec 2003 B1
6673015 Glover et al. Jan 2004 B1
6673064 Rentrop Jan 2004 B1
6685648 Flaherty et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6689144 Gerberding Feb 2004 B2
6696173 Naundorf et al. Feb 2004 B1
6701044 Arbore et al. Mar 2004 B2
6701176 Halperin et al. Mar 2004 B1
6709444 Makower Mar 2004 B1
6712836 Berg et al. Mar 2004 B1
6714703 Lee et al. Mar 2004 B2
6719717 Johnson et al. Apr 2004 B1
6725073 Motamedi et al. Apr 2004 B1
6726677 Flaherty et al. Apr 2004 B1
6730107 Kelley et al. May 2004 B2
6733474 Kusleika May 2004 B2
6738144 Dogariu May 2004 B1
6740113 Vrba May 2004 B2
6746464 Makower Jun 2004 B1
6780157 Stephens et al. Aug 2004 B2
6795188 Ruck et al. Sep 2004 B2
6795196 Funakawa Sep 2004 B2
6798522 Stolte et al. Sep 2004 B2
6822798 Wu et al. Nov 2004 B2
6830559 Schock Dec 2004 B2
6832024 Gerstenberger et al. Dec 2004 B2
6842639 Winston et al. Jan 2005 B1
6847449 Bashkansky et al. Jan 2005 B2
6855115 Fonseca et al. Feb 2005 B2
6856138 Bohley Feb 2005 B2
6856400 Froggatt Feb 2005 B1
6856472 Herman et al. Feb 2005 B2
6860867 Seward et al. Mar 2005 B2
6866670 Rabiner et al. Mar 2005 B2
6878113 Miwa et al. Apr 2005 B2
6886411 Kjellman et al. May 2005 B2
6891984 Petersen et al. May 2005 B2
6895106 Wang et al. May 2005 B2
6898337 Averett et al. May 2005 B2
6900897 Froggatt May 2005 B2
6912051 Jensen Jun 2005 B2
6916329 Zhao Jul 2005 B1
6922498 Shah Jul 2005 B2
6937346 Nebendahl et al. Aug 2005 B2
6937696 Mostafavi Aug 2005 B1
6943939 DiJaili et al. Sep 2005 B1
6947147 Motamedi et al. Sep 2005 B2
6947787 Webler Sep 2005 B2
6949094 Yaron Sep 2005 B2
6952603 Gerber et al. Oct 2005 B2
6954737 Kalantar et al. Oct 2005 B2
6958042 Honda Oct 2005 B2
6961123 Wang et al. Nov 2005 B1
6966891 Ookubo et al. Nov 2005 B2
6969293 Thai Nov 2005 B2
6969395 Eskuri Nov 2005 B2
6985234 Anderson Jan 2006 B2
7004963 Wang et al. Feb 2006 B2
7006231 Ostrovsky et al. Feb 2006 B2
7010458 Wilt Mar 2006 B2
7024025 Sathyanarayana Apr 2006 B2
7027211 Ruffa Apr 2006 B1
7027743 Tucker et al. Apr 2006 B1
7033347 Appling Apr 2006 B2
7035484 Silberberg et al. Apr 2006 B2
7037269 Nix et al. May 2006 B2
7042573 Froggatt May 2006 B2
7044915 White et al. May 2006 B2
7044964 Jang et al. May 2006 B2
7048711 Rosenman et al. May 2006 B2
7049306 Konradi et al. May 2006 B2
7058239 Singh et al. Jun 2006 B2
7060033 White et al. Jun 2006 B2
7060421 Naundorf et al. Jun 2006 B2
7063679 Maguire et al. Jun 2006 B2
7068852 Braica Jun 2006 B2
7074188 Nair et al. Jul 2006 B2
7095493 Harres Aug 2006 B2
7110119 Maestle Sep 2006 B2
7113875 Terashima et al. Sep 2006 B2
7123777 Rondinelli et al. Oct 2006 B2
7130054 Ostrovsky et al. Oct 2006 B2
7139440 Rondinelli et al. Nov 2006 B2
7153299 Tu et al. Dec 2006 B1
7171078 Sasaki et al. Jan 2007 B2
7175597 Vince et al. Feb 2007 B2
7177491 Dave et al. Feb 2007 B2
7190464 Alphonse Mar 2007 B2
7215802 Klingensmith et al. May 2007 B2
7218811 Shigenaga et al. May 2007 B2
7236812 Ballerstadt et al. Jun 2007 B1
7245125 Harer et al. Jul 2007 B2
7245789 Bates et al. Jul 2007 B2
7249357 Landman et al. Jul 2007 B2
7291146 Steinke et al. Nov 2007 B2
7292715 Furnish Nov 2007 B2
7292885 Scott et al. Nov 2007 B2
7294124 Eidenschink Nov 2007 B2
7300460 Levine et al. Nov 2007 B2
7335161 Von Arx et al. Feb 2008 B2
7337079 Park et al. Feb 2008 B2
7355716 de Boer et al. Apr 2008 B2
7356367 Liang et al. Apr 2008 B2
7358921 Snyder et al. Apr 2008 B2
7359062 Chen et al. Apr 2008 B2
7359554 Klingensmith et al. Apr 2008 B2
7363927 Ravikumar Apr 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7387636 Cohn et al. Jun 2008 B2
7391520 Zhou et al. Jun 2008 B2
7397935 Kimmel et al. Jul 2008 B2
7399095 Rondinelli Jul 2008 B2
7408648 Kleen et al. Aug 2008 B2
7414779 Huber et al. Aug 2008 B2
7440087 Froggatt et al. Oct 2008 B2
7447388 Bates et al. Nov 2008 B2
7449821 Dausch Nov 2008 B2
7450165 Ahiska Nov 2008 B2
RE40608 Glover et al. Dec 2008 E
7458967 Appling et al. Dec 2008 B2
7463362 Lasker et al. Dec 2008 B2
7463759 Klingensmith et al. Dec 2008 B2
7491226 Palmaz et al. Feb 2009 B2
7515276 Froggatt et al. Apr 2009 B2
7527594 Vardi et al. May 2009 B2
7534251 WasDyke May 2009 B2
7535797 Peng et al. May 2009 B2
7547304 Johnson Jun 2009 B2
7564949 Sattler et al. Jul 2009 B2
7577471 Camus et al. Aug 2009 B2
7583857 Xu et al. Sep 2009 B2
7603165 Townsend et al. Oct 2009 B2
7612773 Magnin et al. Nov 2009 B2
7633627 Choma et al. Dec 2009 B2
7645229 Armstrong Jan 2010 B2
7658715 Park et al. Feb 2010 B2
7660452 Zwirn et al. Feb 2010 B2
7660492 Bates et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7672790 McGraw et al. Mar 2010 B2
7680247 Atzinger et al. Mar 2010 B2
7684991 Stohr et al. Mar 2010 B2
7711413 Feldman et al. May 2010 B2
7720322 Prisco May 2010 B2
7728986 Lasker et al. Jun 2010 B2
7734009 Brunner et al. Jun 2010 B2
7736317 Stephens et al. Jun 2010 B2
7742795 Stone et al. Jun 2010 B2
7743189 Brown et al. Jun 2010 B2
7762954 Nix et al. Jul 2010 B2
7766896 Kornkven Volk et al. Aug 2010 B2
7773792 Kimmel et al. Aug 2010 B2
7775981 Guracar et al. Aug 2010 B1
7777399 Eidenschink et al. Aug 2010 B2
7781724 Childers et al. Aug 2010 B2
7783337 Feldman et al. Aug 2010 B2
7787127 Galle et al. Aug 2010 B2
7789892 Johnson et al. Sep 2010 B2
7792342 Barbu et al. Sep 2010 B2
7801343 Unal et al. Sep 2010 B2
7801590 Feldman et al. Sep 2010 B2
7813609 Petersen et al. Oct 2010 B2
7831081 Li Nov 2010 B2
7846101 Eberle et al. Dec 2010 B2
7853104 Oota et al. Dec 2010 B2
7853316 Milner et al. Dec 2010 B2
7854747 Johnson et al. Dec 2010 B2
7860555 Saadat Dec 2010 B2
7862508 Davies et al. Jan 2011 B2
7872759 Tearney et al. Jan 2011 B2
7880868 Aoki Feb 2011 B2
7881763 Brauker et al. Feb 2011 B2
7909844 Alkhatib et al. Mar 2011 B2
7921854 Hennings et al. Apr 2011 B2
7927784 Simpson Apr 2011 B2
7929148 Kemp Apr 2011 B2
7930014 Huennekens et al. Apr 2011 B2
7930104 Baker et al. Apr 2011 B2
7936462 Jiang et al. May 2011 B2
7942852 Mas et al. May 2011 B2
7947012 Spurchise et al. May 2011 B2
7951186 Eidenschink et al. May 2011 B2
7952719 Brennan, III May 2011 B2
7972353 Hendriksen et al. Jul 2011 B2
7976492 Brauker et al. Jul 2011 B2
7977950 Maslen Jul 2011 B2
7978916 Klingensmith et al. Jul 2011 B2
7981041 McGahan Jul 2011 B2
7981151 Rowe Jul 2011 B2
7983737 Feldman et al. Jul 2011 B2
7993333 Oral et al. Aug 2011 B2
7995210 Tearney et al. Aug 2011 B2
7996060 Trofimov et al. Aug 2011 B2
7999938 Wang Aug 2011 B2
8021377 Eskuri Sep 2011 B2
8021420 Dolan Sep 2011 B2
8036732 Milner Oct 2011 B2
8040586 Smith et al. Oct 2011 B2
8047996 Goodnow et al. Nov 2011 B2
8049900 Kemp et al. Nov 2011 B2
8050478 Li et al. Nov 2011 B2
8050523 Younge et al. Nov 2011 B2
8052605 Muller et al. Nov 2011 B2
8057394 Dala-Krishna Nov 2011 B2
8059923 Bates et al. Nov 2011 B2
8070800 Lock et al. Dec 2011 B2
8080800 Hoctor et al. Dec 2011 B2
8088102 Adams et al. Jan 2012 B2
8100838 Wright et al. Jan 2012 B2
8104479 Glynn et al. Jan 2012 B2
8108030 Castella et al. Jan 2012 B2
8114102 Galdonik et al. Feb 2012 B2
8116605 Petersen et al. Feb 2012 B2
8125648 Milner et al. Feb 2012 B2
8126239 Sun et al. Feb 2012 B2
8133199 Weber et al. Mar 2012 B2
8133269 Flechsenhar et al. Mar 2012 B2
8140708 Zaharia et al. Mar 2012 B2
8148877 Jiang et al. Apr 2012 B2
8167932 Bourang et al. May 2012 B2
8172757 Jaffe et al. May 2012 B2
8177809 Mavani et al. May 2012 B2
8187191 Hancock et al. May 2012 B2
8187267 Pappone et al. May 2012 B2
8187830 Hu et al. May 2012 B2
8199218 Lee et al. Jun 2012 B2
8206429 Gregorich et al. Jun 2012 B2
8208995 Tearney et al. Jun 2012 B2
8222906 Wyar et al. Jul 2012 B2
8233681 Aylward et al. Jul 2012 B2
8233718 Klingensmith et al. Jul 2012 B2
8238624 Doi et al. Aug 2012 B2
8239938 Simeral et al. Aug 2012 B2
8273099 Dimatteo Sep 2012 B2
8277386 Ahmed et al. Oct 2012 B2
8280470 Milner et al. Oct 2012 B2
8289284 Glynn et al. Oct 2012 B2
8289522 Tearney et al. Oct 2012 B2
8298147 Huennekens et al. Oct 2012 B2
8298149 Hastings et al. Oct 2012 B2
8301000 Sillard et al. Oct 2012 B2
8309428 Lemmerhirt et al. Nov 2012 B2
8317713 Davies et al. Nov 2012 B2
8323201 Towfiq et al. Dec 2012 B2
8329053 Martin et al. Dec 2012 B2
8336643 Harleman Dec 2012 B2
8349000 Schreck Jan 2013 B2
8353945 Andreas et al. Jan 2013 B2
8353954 Cai et al. Jan 2013 B2
8357981 Martin et al. Jan 2013 B2
8361097 Patel et al. Jan 2013 B2
8386560 Ma et al. Feb 2013 B2
8398591 Mas et al. Mar 2013 B2
8412312 Judell et al. Apr 2013 B2
8417491 Trovato et al. Apr 2013 B2
8449465 Nair et al. May 2013 B2
8454685 Hariton et al. Jun 2013 B2
8454686 Alkhatib Jun 2013 B2
8475522 Jimenez et al. Jul 2013 B2
8478384 Schmitt et al. Jul 2013 B2
8486062 Belhe et al. Jul 2013 B2
8486063 Werneth et al. Jul 2013 B2
8491567 Magnin et al. Jul 2013 B2
8500798 Rowe et al. Aug 2013 B2
8550911 Sylla Oct 2013 B2
8594757 Boppart et al. Nov 2013 B2
8597349 Alkhatib Dec 2013 B2
8600477 Beyar et al. Dec 2013 B2
8600917 Schimert et al. Dec 2013 B1
8601056 Lauwers et al. Dec 2013 B2
8620055 Barratt et al. Dec 2013 B2
8644910 Rousso et al. Feb 2014 B2
20010007940 Tu et al. Jul 2001 A1
20010029337 Pantages et al. Oct 2001 A1
20010037073 White et al. Nov 2001 A1
20010046345 Snyder et al. Nov 2001 A1
20010049548 Vardi et al. Dec 2001 A1
20020034276 Hu et al. Mar 2002 A1
20020041723 Ronnekleiv et al. Apr 2002 A1
20020069676 Kopp, II et al. Jun 2002 A1
20020089335 Williams Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020099289 Crowley Jul 2002 A1
20020163646 Anderson Nov 2002 A1
20020186818 Arnaud et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20020196446 Roth et al. Dec 2002 A1
20020197456 Pope Dec 2002 A1
20030004412 Izatt et al. Jan 2003 A1
20030016604 Hanes Jan 2003 A1
20030018273 Corl et al. Jan 2003 A1
20030023153 Izatt et al. Jan 2003 A1
20030032886 Dgany et al. Feb 2003 A1
20030050871 Broughton Mar 2003 A1
20030065371 Satake Apr 2003 A1
20030069723 Hegde Apr 2003 A1
20030077043 Hamm et al. Apr 2003 A1
20030085635 Davidsen May 2003 A1
20030090753 Takeyama et al. May 2003 A1
20030092995 Thompson May 2003 A1
20030093059 Griffin et al. May 2003 A1
20030103212 Westphal et al. Jun 2003 A1
20030152259 Belykh et al. Aug 2003 A1
20030171774 Freudenthal et al. Sep 2003 A1
20030181802 Ogawa Sep 2003 A1
20030187369 Lewis et al. Oct 2003 A1
20030194165 Silberberg et al. Oct 2003 A1
20030195419 Harada Oct 2003 A1
20030208116 Liang et al. Nov 2003 A1
20030212491 Mitchell et al. Nov 2003 A1
20030219202 Loeb et al. Nov 2003 A1
20030220749 Chen et al. Nov 2003 A1
20030228039 Green Dec 2003 A1
20040015065 Panescu et al. Jan 2004 A1
20040023317 Motamedi et al. Feb 2004 A1
20040028333 Lomas Feb 2004 A1
20040037742 Jen et al. Feb 2004 A1
20040042066 Kinoshita et al. Mar 2004 A1
20040054287 Stephens Mar 2004 A1
20040067000 Bates et al. Apr 2004 A1
20040068161 Couvillon Apr 2004 A1
20040082844 Vardi et al. Apr 2004 A1
20040092830 Scott et al. May 2004 A1
20040106853 Moriyama Jun 2004 A1
20040111552 Arimilli et al. Jun 2004 A1
20040126048 Dave et al. Jul 2004 A1
20040143160 Couvillon Jul 2004 A1
20040146546 Gravett et al. Jul 2004 A1
20040186369 Lam Sep 2004 A1
20040186512 Bruckheimer et al. Sep 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040195512 Crosetto Oct 2004 A1
20040199201 Kellett et al. Oct 2004 A1
20040220606 Goshgarian Nov 2004 A1
20040225220 Rich Nov 2004 A1
20040239938 Izatt Dec 2004 A1
20040242990 Brister et al. Dec 2004 A1
20040248439 Gernhardt et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050013778 Green et al. Jan 2005 A1
20050031176 Hertel et al. Feb 2005 A1
20050036150 Izatt et al. Feb 2005 A1
20050078317 Law et al. Apr 2005 A1
20050101859 Maschke May 2005 A1
20050140582 Lee et al. Jun 2005 A1
20050140682 Sumanaweera et al. Jun 2005 A1
20050140981 Waelti Jun 2005 A1
20050140984 Hitzenberger Jun 2005 A1
20050147303 Zhou et al. Jul 2005 A1
20050165439 Weber et al. Jul 2005 A1
20050171433 Boppart et al. Aug 2005 A1
20050171438 Chen et al. Aug 2005 A1
20050177185 Becker et al. Aug 2005 A1
20050182297 Gravenstein et al. Aug 2005 A1
20050196028 Kleen et al. Sep 2005 A1
20050197585 Brockway et al. Sep 2005 A1
20050213103 Everett et al. Sep 2005 A1
20050215942 Abrahamson et al. Sep 2005 A1
20050234445 Conquergood et al. Oct 2005 A1
20050243322 Lasker et al. Nov 2005 A1
20050249391 Kimmel et al. Nov 2005 A1
20050251567 Ballew et al. Nov 2005 A1
20050254059 Alphonse Nov 2005 A1
20050264823 Zhu et al. Dec 2005 A1
20060013523 Childlers et al. Jan 2006 A1
20060015126 Sher Jan 2006 A1
20060020285 Niermann Jan 2006 A1
20060029634 Berg et al. Feb 2006 A1
20060036167 Shina Feb 2006 A1
20060038115 Maas Feb 2006 A1
20060039004 de Boer et al. Feb 2006 A1
20060041180 Viswanathan et al. Feb 2006 A1
20060045536 Arahira Mar 2006 A1
20060055936 Yun et al. Mar 2006 A1
20060058622 Tearney et al. Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060067620 Shishkov et al. Mar 2006 A1
20060069405 Schaeffer Mar 2006 A1
20060072808 Grimm et al. Apr 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060098927 Schmidt et al. May 2006 A1
20060100694 Globerman May 2006 A1
20060106375 Werneth et al. May 2006 A1
20060132790 Gutin Jun 2006 A1
20060135870 Webler Jun 2006 A1
20060142703 Carter et al. Jun 2006 A1
20060142733 Forsberg Jun 2006 A1
20060173299 Romley et al. Aug 2006 A1
20060179255 Yamazaki Aug 2006 A1
20060184048 Saadat Aug 2006 A1
20060187537 Huber et al. Aug 2006 A1
20060195269 Yeatman et al. Aug 2006 A1
20060204119 Feng et al. Sep 2006 A1
20060229591 Lee Oct 2006 A1
20060239312 Kewitsch et al. Oct 2006 A1
20060241342 Macaulay et al. Oct 2006 A1
20060241465 Huennekens et al. Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060241675 Johnson et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060258895 Maschke Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060267756 Kates Nov 2006 A1
20060270976 Savage et al. Nov 2006 A1
20060276709 Khamene et al. Dec 2006 A1
20060279742 Tearney et al. Dec 2006 A1
20060279743 Boesser et al. Dec 2006 A1
20060285638 Boese et al. Dec 2006 A1
20060287595 Maschke Dec 2006 A1
20060293597 Johnson et al. Dec 2006 A1
20070015969 Feldman et al. Jan 2007 A1
20070016029 Donaldson et al. Jan 2007 A1
20070016034 Donaldson Jan 2007 A1
20070016062 Park et al. Jan 2007 A1
20070027390 Maschke et al. Feb 2007 A1
20070036417 Argiro et al. Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038121 Feldman et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070043292 Camus et al. Feb 2007 A1
20070043597 Donaldson Feb 2007 A1
20070049847 Osborne Mar 2007 A1
20070060973 Ludvig et al. Mar 2007 A1
20070065077 Childers et al. Mar 2007 A1
20070066888 Maschke Mar 2007 A1
20070066890 Maschke Mar 2007 A1
20070066983 Maschke Mar 2007 A1
20070084995 Newton et al. Apr 2007 A1
20070100226 Yankelevitz et al. May 2007 A1
20070135887 Maschke Jun 2007 A1
20070142707 Wiklof et al. Jun 2007 A1
20070156019 Larkin et al. Jul 2007 A1
20070161893 Milner et al. Jul 2007 A1
20070161896 Adachi et al. Jul 2007 A1
20070161963 Smalling Jul 2007 A1
20070162860 Muralidharan et al. Jul 2007 A1
20070165141 Srinivas et al. Jul 2007 A1
20070167710 Unal et al. Jul 2007 A1
20070167804 Park et al. Jul 2007 A1
20070191682 Rolland et al. Aug 2007 A1
20070201736 Klingensmith et al. Aug 2007 A1
20070206193 Pesach Sep 2007 A1
20070208276 Kornkven Volk et al. Sep 2007 A1
20070225220 Ming et al. Sep 2007 A1
20070225590 Ramos Sep 2007 A1
20070229801 Tearney et al. Oct 2007 A1
20070232872 Prough et al. Oct 2007 A1
20070232874 Ince Oct 2007 A1
20070232890 Hirota Oct 2007 A1
20070232891 Hirota Oct 2007 A1
20070232892 Hirota Oct 2007 A1
20070232893 Tanioka Oct 2007 A1
20070232933 Gille et al. Oct 2007 A1
20070238957 Yared Oct 2007 A1
20070247033 Eidenschink et al. Oct 2007 A1
20070250000 Magnin et al. Oct 2007 A1
20070250036 Volk et al. Oct 2007 A1
20070258094 Izatt et al. Nov 2007 A1
20070260138 Feldman et al. Nov 2007 A1
20070278389 Ajgaonkar et al. Dec 2007 A1
20070287914 Cohen Dec 2007 A1
20080002183 Yatagai et al. Jan 2008 A1
20080013093 Izatt et al. Jan 2008 A1
20080021275 Tearney et al. Jan 2008 A1
20080027481 Gilson et al. Jan 2008 A1
20080033534 Cook et al. Feb 2008 A1
20080043024 Schiwietz et al. Feb 2008 A1
20080045842 Furnish Feb 2008 A1
20080051660 Kakadaris et al. Feb 2008 A1
20080063304 Russak et al. Mar 2008 A1
20080085041 Breeuwer Apr 2008 A1
20080095465 Mullick et al. Apr 2008 A1
20080095714 Castella et al. Apr 2008 A1
20080097194 Milner Apr 2008 A1
20080101667 Begelman et al. May 2008 A1
20080108867 Zhou May 2008 A1
20080114254 Matcovitch et al. May 2008 A1
20080119739 Vardi et al. May 2008 A1
20080124495 Horn et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080143707 Mitchell Jun 2008 A1
20080146941 Dala-Krishna Jun 2008 A1
20080147111 Johnson Jun 2008 A1
20080154128 Milner Jun 2008 A1
20080161696 Schmitt et al. Jul 2008 A1
20080171944 Brenneman et al. Jul 2008 A1
20080175465 Jiang et al. Jul 2008 A1
20080177183 Courtney et al. Jul 2008 A1
20080180683 Kemp Jul 2008 A1
20080181477 Izatt et al. Jul 2008 A1
20080187201 Liang et al. Aug 2008 A1
20080228086 Ilegbusi et al. Sep 2008 A1
20080247622 Aylward et al. Oct 2008 A1
20080247716 Thomas et al. Oct 2008 A1
20080262470 Lee et al. Oct 2008 A1
20080262489 Steinke Oct 2008 A1
20080269599 Csavoy et al. Oct 2008 A1
20080281205 Naghavi et al. Nov 2008 A1
20080281248 Angheloiu et al. Nov 2008 A1
20080285043 Fercher et al. Nov 2008 A1
20080287795 Klingensmith et al. Nov 2008 A1
20080291463 Milner et al. Nov 2008 A1
20080292173 Hsieh et al. Nov 2008 A1
20080294034 Krueger et al. Nov 2008 A1
20080298655 Edwards Dec 2008 A1
20080306766 Ozeki et al. Dec 2008 A1
20090009801 Tabuki Jan 2009 A1
20090018393 Dick et al. Jan 2009 A1
20090034813 Dikmen et al. Feb 2009 A1
20090043191 Castella et al. Feb 2009 A1
20090046295 Kemp et al. Feb 2009 A1
20090052614 Hempel et al. Feb 2009 A1
20090069843 Agnew Mar 2009 A1
20090079993 Yatagai et al. Mar 2009 A1
20090088650 Corl Apr 2009 A1
20090093980 Kemp et al. Apr 2009 A1
20090122320 Petersen et al. May 2009 A1
20090138544 Wegenkittl et al. May 2009 A1
20090149739 Maschke Jun 2009 A9
20090156941 Moore Jun 2009 A1
20090174886 Inoue Jul 2009 A1
20090174931 Huber et al. Jul 2009 A1
20090177090 Grunwald et al. Jul 2009 A1
20090177183 Pinkernell et al. Jul 2009 A1
20090195514 Glynn et al. Aug 2009 A1
20090196470 Carl et al. Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090203991 Papaioannou et al. Aug 2009 A1
20090264768 Courtney et al. Oct 2009 A1
20090269014 Winberg et al. Oct 2009 A1
20090270695 McEowen Oct 2009 A1
20090284322 Harrison et al. Nov 2009 A1
20090284332 Moore et al. Nov 2009 A1
20090284749 Johnson et al. Nov 2009 A1
20090290167 Flanders et al. Nov 2009 A1
20090292048 Li et al. Nov 2009 A1
20090299195 Muller et al. Dec 2009 A1
20090299284 Holman et al. Dec 2009 A1
20090318951 Kashkarov et al. Dec 2009 A1
20090326634 Vardi Dec 2009 A1
20100007669 Bethune et al. Jan 2010 A1
20100030042 Denninghoff et al. Feb 2010 A1
20100061611 Xu et al. Mar 2010 A1
20100063400 Hall et al. Mar 2010 A1
20100087732 Eberle et al. Apr 2010 A1
20100094125 Younge et al. Apr 2010 A1
20100094127 Xu Apr 2010 A1
20100094135 Fang-Yen et al. Apr 2010 A1
20100094143 Mahapatra et al. Apr 2010 A1
20100113919 Maschke May 2010 A1
20100125238 Lye et al. May 2010 A1
20100125268 Gustus et al. May 2010 A1
20100125648 Zaharia et al. May 2010 A1
20100128348 Taverner May 2010 A1
20100130963 Ebert et al. May 2010 A1
20100152717 Keeler Jun 2010 A1
20100160788 Davies et al. Jun 2010 A1
20100161023 Cohen et al. Jun 2010 A1
20100168714 Burke et al. Jul 2010 A1
20100179421 Tupin Jul 2010 A1
20100179426 Davies et al. Jul 2010 A1
20100220334 Condit et al. Sep 2010 A1
20100226607 Zhang et al. Sep 2010 A1
20100234736 Corl Sep 2010 A1
20100249601 Courtney Sep 2010 A1
20100256616 Katoh et al. Oct 2010 A1
20100268265 Krolik et al. Oct 2010 A1
20100272432 Johnson Oct 2010 A1
20100284590 Peng et al. Nov 2010 A1
20100290693 Cohen et al. Nov 2010 A1
20100331950 Strommer Dec 2010 A1
20110010925 Nix et al. Jan 2011 A1
20110021926 Spencer et al. Jan 2011 A1
20110025853 Richardson Feb 2011 A1
20110026797 Declerck et al. Feb 2011 A1
20110032533 Izatt et al. Feb 2011 A1
20110034801 Baumgart Feb 2011 A1
20110034802 Shrivastava Feb 2011 A1
20110044546 Pan et al. Feb 2011 A1
20110066073 Kuiper et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110072405 Chen et al. Mar 2011 A1
20110077528 Kemp et al. Mar 2011 A1
20110080591 Johnson et al. Apr 2011 A1
20110087104 Moore et al. Apr 2011 A1
20110137140 Tearney et al. Jun 2011 A1
20110144502 Zhou et al. Jun 2011 A1
20110152771 Milner et al. Jun 2011 A1
20110157597 Lu et al. Jun 2011 A1
20110160586 Li et al. Jun 2011 A1
20110178413 Schmitt et al. Jul 2011 A1
20110190586 Kemp Aug 2011 A1
20110216378 Poon et al. Sep 2011 A1
20110220985 Son et al. Sep 2011 A1
20110238061 van der Weide et al. Sep 2011 A1
20110238083 Moll et al. Sep 2011 A1
20110245669 Zhang Oct 2011 A1
20110249094 Wang et al. Oct 2011 A1
20110257545 Suri Oct 2011 A1
20110264125 Wilson et al. Oct 2011 A1
20110274329 Mathew et al. Nov 2011 A1
20110282334 Groenhoff Nov 2011 A1
20110301684 Fischell et al. Dec 2011 A1
20110306995 Moberg Dec 2011 A1
20110319752 Steinberg et al. Dec 2011 A1
20120004529 Tolkowsky et al. Jan 2012 A1
20120004668 Wallace et al. Jan 2012 A1
20120013914 Kemp et al. Jan 2012 A1
20120016344 Kusakabe Jan 2012 A1
20120016395 Olson Jan 2012 A1
20120022360 Kemp Jan 2012 A1
20120022638 Leewood et al. Jan 2012 A1
20120026503 Lewandowski et al. Feb 2012 A1
20120029007 Graham et al. Feb 2012 A1
20120059253 Wang et al. Mar 2012 A1
20120059368 Takaoka et al. Mar 2012 A1
20120062843 Ferguson et al. Mar 2012 A1
20120065481 Hunter et al. Mar 2012 A1
20120071823 Chen Mar 2012 A1
20120071838 Fojtik Mar 2012 A1
20120075638 Rollins et al. Mar 2012 A1
20120083696 Kitamura Apr 2012 A1
20120095340 Smith Apr 2012 A1
20120095372 Sverdlik et al. Apr 2012 A1
20120108943 Bates et al. May 2012 A1
20120113108 Dala-Krishna May 2012 A1
20120116353 Arnold et al. May 2012 A1
20120130243 Balocco et al. May 2012 A1
20120130247 Waters et al. May 2012 A1
20120136259 Milner et al. May 2012 A1
20120136427 Palmaz et al. May 2012 A1
20120137075 Vorbach May 2012 A1
20120155734 Barratt et al. Jun 2012 A1
20120158101 Stone et al. Jun 2012 A1
20120162660 Kemp Jun 2012 A1
20120165661 Kemp et al. Jun 2012 A1
20120170848 Kemp et al. Jul 2012 A1
20120172698 Teo et al. Jul 2012 A1
20120176607 Ott Jul 2012 A1
20120184853 Waters Jul 2012 A1
20120184859 Shah et al. Jul 2012 A1
20120184977 Wolf Jul 2012 A1
20120215094 Rahimian et al. Aug 2012 A1
20120220836 Alpert et al. Aug 2012 A1
20120220851 Razansky et al. Aug 2012 A1
20120220865 Brown et al. Aug 2012 A1
20120220874 Hancock et al. Aug 2012 A1
20120220883 Manstrom et al. Aug 2012 A1
20120224751 Kemp et al. Sep 2012 A1
20120226153 Brown et al. Sep 2012 A1
20120230565 Steinberg et al. Sep 2012 A1
20120232400 Dickinson et al. Sep 2012 A1
20120238869 Schmitt et al. Sep 2012 A1
20120238956 Yamada et al. Sep 2012 A1
20120244043 Leblanc et al. Sep 2012 A1
20120250028 Schmitt et al. Oct 2012 A1
20120253186 Simpson et al. Oct 2012 A1
20120253192 Cressman Oct 2012 A1
20120253276 Govari et al. Oct 2012 A1
20120257210 Whitney et al. Oct 2012 A1
20120262720 Brown et al. Oct 2012 A1
20120265077 Gille et al. Oct 2012 A1
20120265268 Blum et al. Oct 2012 A1
20120265296 McNamara et al. Oct 2012 A1
20120271170 Emelianov et al. Oct 2012 A1
20120271175 Moore et al. Oct 2012 A1
20120271339 O'Beirne et al. Oct 2012 A1
20120274338 Baks et al. Nov 2012 A1
20120276390 Ji et al. Nov 2012 A1
20120277722 Gerber et al. Nov 2012 A1
20120279764 Jiang et al. Nov 2012 A1
20120283758 Miller et al. Nov 2012 A1
20120289987 Wilson et al. Nov 2012 A1
20120299439 Huang Nov 2012 A1
20120310081 Adler et al. Dec 2012 A1
20120310332 Murray et al. Dec 2012 A1
20120319535 Dausch Dec 2012 A1
20120323075 Younge et al. Dec 2012 A1
20120323127 Boyden et al. Dec 2012 A1
20120330141 Brown et al. Dec 2012 A1
20130012981 Johnson et al. Jan 2013 A1
20130015975 Huennekens et al. Jan 2013 A1
20130023762 Huennekens et al. Jan 2013 A1
20130023763 Huennekens et al. Jan 2013 A1
20130023981 Dierking et al. Jan 2013 A1
20130026655 Lee et al. Jan 2013 A1
20130030295 Huennekens et al. Jan 2013 A1
20130030303 Ahmed et al. Jan 2013 A1
20130030410 Drasler et al. Jan 2013 A1
20130053949 Pintor et al. Feb 2013 A1
20130109958 Baumgart et al. May 2013 A1
20130109959 Baumgart et al. May 2013 A1
20130137980 Waters et al. May 2013 A1
20130150716 Stigall et al. Jun 2013 A1
20130158594 Carrison et al. Jun 2013 A1
20130218201 Obermiller et al. Aug 2013 A1
20130218267 Braido et al. Aug 2013 A1
20130223789 Lee et al. Aug 2013 A1
20130223798 Jenner et al. Aug 2013 A1
20130289519 Johnson et al. Oct 2013 A1
20130289610 Johnson et al. Oct 2013 A1
20130296704 Magnin et al. Nov 2013 A1
20130303907 Corl Nov 2013 A1
20130303920 Corl Nov 2013 A1
20130310698 Judell et al. Nov 2013 A1
20130331820 Itou et al. Dec 2013 A1
20130338766 Hastings et al. Dec 2013 A1
20130339958 Droste et al. Dec 2013 A1
20140039294 Jiang Feb 2014 A1
20140180067 Stigall et al. Jun 2014 A1
20140180128 Corl Jun 2014 A1
20140200438 Millett et al. Jul 2014 A1
20150164630 Johnson et al. Jun 2015 A1
20150173830 Johnson et al. Jun 2015 A1
20150173884 Johnson et al. Jun 2015 A1
20150173924 Johnson et al. Jun 2015 A1
20160030151 Johnson et al. Feb 2016 A1
20160030152 Johnson et al. Feb 2016 A1
Foreign Referenced Citations (88)
Number Date Country
2635045 Aug 2004 CN
101965161 Feb 2011 CN
1041373 Oct 2000 EP
01172637 Jan 2002 EP
2438877 Apr 2012 EP
1588072 Apr 1981 GB
2280261 Jan 1995 GB
2000-262461 Sep 2000 JP
2000-292260 Oct 2000 JP
2001-125009 May 2001 JP
2001-272331 Oct 2001 JP
2002-374034 Dec 2002 JP
2003-143783 May 2003 JP
2003-172690 Jun 2003 JP
2003-256876 Sep 2003 JP
2003-287534 Oct 2003 JP
2005-274380 Oct 2005 JP
2006-184284 Jul 2006 JP
2006-266797 Oct 2006 JP
2006-313158 Nov 2006 JP
2007-024677 Feb 2007 JP
2009-233001 Oct 2009 JP
2011-56786 Mar 2011 JP
9101156 Feb 1991 WO
9216865 Oct 1992 WO
9306213 Apr 1993 WO
9308829 May 1993 WO
9838907 Sep 1998 WO
9857583 Dec 1998 WO
0011511 Mar 2000 WO
00044296 Aug 2000 WO
0111409 Feb 2001 WO
03062802 Jul 2003 WO
03073950 Sep 2003 WO
2004010856 Feb 2004 WO
2004023992 Mar 2004 WO
2004096049 Nov 2004 WO
2005047813 May 2005 WO
2005106695 May 2005 WO
2005102211 Nov 2005 WO
2005102211 Nov 2005 WO
2006029634 Mar 2006 WO
2006034233 Mar 2006 WO
2006037132 Apr 2006 WO
2006039091 Apr 2006 WO
2006061829 Jun 2006 WO
2006068875 Jun 2006 WO
2006111704 Oct 2006 WO
2006119416 Nov 2006 WO
2006121851 Nov 2006 WO
2006130802 Dec 2006 WO
2007002685 Jan 2007 WO
2007025230 Mar 2007 WO
2007045690 Apr 2007 WO
2007058895 May 2007 WO
2007067323 Jun 2007 WO
2007084995 Jul 2007 WO
2008058084 May 2008 WO
2008069991 Jun 2008 WO
2008107905 Sep 2008 WO
2008127983 Oct 2008 WO
2009009799 Jan 2009 WO
2009009801 Jan 2009 WO
2009046431 Apr 2009 WO
2009121067 Oct 2009 WO
2009137704 Nov 2009 WO
2014144362 Dec 2010 WO
201106886 Jan 2011 WO
2011038048 Mar 2011 WO
2011081688 Jul 2011 WO
2012003369 Jan 2012 WO
2012003369 Jan 2012 WO
2012061935 May 2012 WO
2012071388 May 2012 WO
2012087818 Jun 2012 WO
2012098194 Jul 2012 WO
2012109676 Aug 2012 WO
2012130289 Oct 2012 WO
2012154767 Nov 2012 WO
2012155040 Nov 2012 WO
2013033414 Mar 2013 WO
2013033415 Mar 2013 WO
2013033418 Mar 2013 WO
2013033489 Mar 2013 WO
2013033490 Mar 2013 WO
2013033592 Mar 2013 WO
2013126390 Aug 2013 WO
2014109879 Jul 2014 WO
Non-Patent Literature Citations (192)
Entry
Sihan et al., 2008, A novel approach to quantitative analysis of intraluminal optical coherence tomography imaging, Comput. Cardiol:1089-1092.
Siwy et al., 2003, Electro-responsive asymmetric nanopores in polyimide with stable ion-current signal, Applied Physics A: Materials Science & Processing 76:781-785.
Smith et al., 1989, Absolute displacement measurements using modulation of the spectrum of white light in a Michelson interferometer, Applied Optics, 28(16):3339-3342.
Smith, 1997, The Scientist and Engineer's Guide to Digital Signal Processing, California Technical Publishing, San Diego, CA:432-436.
Soller, 2003, Polarization diverse optical frequency domain interferometry:All coupler implementation, Bragg Grating, Photosensitivity, and Poling in Glass Waveguides Conference MB4:30-32.
Song et al., 2012, Active tremor cancellation by a “Smart” handheld vitreoretinal microsurgical tool using swept source optical coherence tomography, Optics Express, 20(21):23414-23421.
Stenqvist et al., 1983, Stiffness of central venous catheters, Acta Anaesthesiol Scand., 2:153-157.
Strickland, 1970, Time-Domain Reflectometer Measurements, Tektronix, Beaverton, OR, (107 pages).
Strobl et al., 2009, An Introduction to Recursive Partitioning:Rationale, Application and Characteristics of Classification and Regression Trees, Bagging and Random Forests, Psychol Methods., 14(4):323-348.
Sutcliffe et al., 1986, Dynamics of UV laser ablation of organic polymer surfaces, Journal of Applied Physics, 60(9):3315-3322.
Suzuki, 2013, A novel guidewire approach for handling acute-angle bifurcations, J Inv Cardiol 25(1):48-54.
Tanimoto et al., 2008, A novel approach for quantitative analysis of intracoronary optical coherence tomography: high inter-observer agreement with computer-assisted contour detection, Cathet Cardiovascular Intervent., 72(2):228-235.
Tearney et al., 1997, In vivo Endoscopic Optical Biopsy with Optical Coherence Tomography, Science, 276:2037-2039.
Tonino et al., 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, The New England Journal of Medicine, 360:213-224.
Toregeani et al., 2008, Evaluation of hemodialysis arteriovenous fistula maturation by color-flow Doppler ultrasound, J Vasc. Bras. 7(3):203-213.
Translation of Notice of Reason(s) for Refusal dated Apr. 30, 2014, for Japanese Patent Application No. 2011-508677, (5 pages).
Translation of Notice of Reason(s) for Refusal dated May 25, 2012, for Japanese Patent Application No. 2009-536425, (3 pages).
Translation of Notice of Reason(s) for Refusal dated Nov. 22, 2012, for Japanese Patent Application No. 2010-516304, (6 pages).
Traunecker et al., 1991, Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells, EMBO J., 10:3655-3659.
Trolier-McKinstry et. al., 2004, Thin Film Piezoelectric for MEMS, Journal of Electroceramics 12:7-17.
Tuniz et al., 2010, Weaving the invisible thread: design of an optically invisible metamaterial fibre, Optics Express 18(17)18095-18105.
Turk et al., 1991, Eigenfaces for Recognition, Journal of Cognitive Neuroscience 3(1):71-86.
Tuzel et al., 2006, Region Covariance: A Fast Descriptor for Detection and Classification, European Conference on Computer Vision (ECCV).
Urban et al., 2010, Design of a Pressure Sensor Based on Optical Bragg Grating Lateral Deformation, Sensors (Basel), 10(12):11212-11225.
Vakhtin et al., 2003, Common-path interferometer for frequency-domain optical coherence tomography, Applied Optics, 42(34):6953-6958.
Vakoc et al., 2005, Phase-Resolved Optical Frequency Domain Imaging, Optics Express 13(14):5483-5493.
Verhoeyen et al., 1988, Reshaping human antibodies: grafting an antilysozyme activity, Science, 239:1534-1536.
Villard et al., 2002, Use of a blood substitute to determine instantaneous murine right ventricular thickening with optical coherence tomography, Circulation, 105:1843-1849.
Wang et al., 2002, Optimizing the Beam Patten of a Forward-Viewing Ring-Annular Ultrasound Array for Intravascular Imaging, Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 49(12).
Wang et al., 2006, Multiple biomarkers for the prediction of first major cardiovascular events and death, The New England Journal of Medicine, 355(25):2631-2639.
Wang et al., 2009, Robust Guidewire Tracking in Fluoroscopy, IEEE Conference on Computer Vision and Pattern Recognition—CVPR 2009:691-698.
Wang et al., 2011, In vivo intracardiac optical coherence tomography imaging through percutaneous access: toward image-guided radio-frequency ablation, J. Biomed. Opt. 0001 16(11):110505-1 (3 pages).
Waterhouse et. al., 1993, Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires, Nucleic Acids Res., 21:2265-2266.
Wegener, 2011, 3D Photonic Metamaterials and Invisibility Cloaks: The Method of Making, MEMS 2011, Cancun, Mexico, Jan. 23-27, 2011.
West et al., 1991, Arterial insufficiency in hemodialysis access procedures: correction by banding technique, Transpl Proc 23(2):1838-40.
Wyawahare et al., 2009, Image registration techniques: an overview, International Journal of Signal Processing, Image Processing and Pattern Recognition, 2(3):11-28.
Yaqoob et al., 2006, Methods and application areas of endoscopic optical coherence tomography, J. Biomed. Opt., 11, 063001-1-063001-19.
Yasuno et al., 2004, Polarization-sensitive complex Fourier domain optical coherence tomography for Jones matrix imaging of biological samples, Applied Physics Letters 85(15):3023-3025.
Zhang et al., 2004, Full range polarization-sensitive Fourier domain optical coherence tomography, Optics Express, 12(24):6033-6039.
Zitova et al., 2003, Image registration methods: A survey. Image and Vision Computing, 21(11):977-1000.
Kinney TB, Update on inferior vena cava filters, JVIR 2003; 14:425-440.
DeWeese MS, A vena cava filter for prevention of pulmonary embolism, Arch of Surg 1963; 86:852-868, incorporate herein by reference.
International Search Report and Written Opinion dated Nov. 2, 2012, for International Patent Application No. PCT/US12/53168, filed Aug. 30, 2013 (8 pages).
International Search Report and Written Opinion dated Apr. 14, 2014, for International Patent Application No. PCT/US2013/076148, filed Dec. 18, 2013 (8 pages).
International Search Report and Written Opinion dated Apr. 21, 2014, for International Patent Application No. PCT/US2013/076015, filed Dec. 18, 2013 (7 pages).
International Search Report and Written Opinion dated Apr. 23, 2014, for International Patent Application No. PCT/US2013/075328, filed Dec. 16, 2013 (8 pages).
International Search Report and Written Opinion dated Apr. 29, 2014, for International Patent Application No. PCT/US13/76093, filed Dec. 18, 2013 (6 pages).
International Search Report and Written Opinion dated Apr. 9, 2014, for International Patent Application No. PCT/US13/75089, filed Dec. 13, 2013 (7 pages).
International Search Report and Written Opinion dated Feb. 21, 2014, for International Patent Application No. PCT/US13/76053, filed Dec. 18, 2013 (9 pages).
International Search Report and Written Opinion dated Feb. 21, 2014, for International Patent Application No. PCT/US2013/076965, filed Dec. 20, 2013 (6 pages).
International Search Report and Written Opinion dated Feb. 27, 2014, for International Patent Application No. PCT/US13/75416, filed Dec. 16, 2013 (7 pages).
International Search Report and Written Opinion dated Feb. 28, 2014, for International Patent Application No. PCT/US13/75653, filed Dec. 17, 2013 (7 pages).
International Search Report and Written Opinion dated Feb. 28, 2014, for International Patent Application No. PCT/US13/75990, filed Dec. 18, 2013 (7 pages).
International Search Report and Written Opinion dated Jan. 16, 2009, for International Patent Application No. PCT/US08/78963 filed on Oct. 6, 2008 (7 Pages).
International Search Report and Written Opinion dated Jul. 30, 2014, for International Patent Application No. PCT/US14/21659, filed Mar. 7, 2014 (15 pages).
International Search Report and Written Opinion dated Mar. 10, 2014, for International Patent Application No. PCT/US2013/076212, filed Dec. 18, 2013 (8 pages).
International Search Report and Written Opinion dated Mar. 11, 2014, for International Patent Application No. PCT/US13/76173, filed Dec. 16, 2013 (9 pages).
International Search Report and Written Opinion dated Mar. 11, 2014, for International Patent Application No. PCT/US13/76449, filed Dec. 19, 2013 (9 pages).
International Search Report and Written Opinion dated Mar. 18, 2014, for International Patent Application No. PCT/US2013/076502, filed Dec. 19, 2013 (7 pages).
International Search Report and Written Opinion dated Mar. 18, 2014, for International Patent Application No. PCT/US2013/076788, filed Dec. 20, 2013 (7 pages).
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US13/75349, filed Dec. 16, 2013 (10 pages).
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US2013/076587, filed Dec. 19, 2013 (10 pages).
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US2013/076909, filed Dec. 20, 2013 (7 pages).
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076304, filed Dec. 18, 2013 (9 pages).
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076480, filed Dec. 19, 2013 (8 pages).
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076512, filed Dec. 19, 2013 (8 pages).
International Search Report and Written Opinion dated Mar. 7, 2014, for International Patent Application No. PCT/US2013/076531, filed Dec. 19, 2013 (10 pages).
Jakobovits et al., 1993, Analysis of homozygous mutant chimeric mice:deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production, PNAS USA 90:2551-255.
Jakobovits et al., 1993, Germ-line transmission and expression of a human-derived yeast artificial chromosome, Nature 362:255-258.
Jang et al., 2002, Visualization of Coronary Atherosclerotic Plaques in Patients Using Optical Coherence Tomography: Comparison With Intravascular Ultrasound, Journal of the American College of Cardiology 39:604-609.
Jiang et al., 1992, Image registration of multimodality 3-D medical images by chamfer matching, Proc. SPIE 1660, Biomedical Image Processing and Three-Dimensional Microscopy, 356-366.
Johnson et al., 1993, Human antibody engineering: Current Opinion in Structural Biology, 3:564-571.
Jones et al., 1986, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, 321:522-525.
Juviler et al., 2008, Anorectal sepsis and fistula-in-ano, Surgical Technology International, 17:139-149.
Karapatis et al., 1998, Direct rapid tooling:a review of current research, Rapid Prototyping Journal, 4(2):77-89.
Karp et al., 2009, The benefit of time-of-flight in PET imaging, J Nucl Med 49:462-470.
Kelly et al., 2005, Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle, Circulation Research 96:327-336.
Kemp et al., 2005, Depth Resolved Optic Axis Orientation in Multiple Layered Anisotropic Tissues Measured with Enhanced Polarization Sensitive Optical Coherence Tomography, Optics Express 13(12):4507-4518.
Kersey et al., 1991, Polarization insensitive fiber optic Michelson interferometer, Electron. Lett. 27:518-520.
Kheir et al., 2012, Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery, Science Translational Medicine 4(140):140ra88 (10 pages).
Khuri-Yakub et al., 2011, Capacitive micromachined ultrasonic transducers for medical imaging and therapy, J Micromech Microeng. 21(5):054004-054014.
Kirkman, 1991, Technique for flow reduction in dialysis access fistulas, Surg Gyn Obstet, 172(3):231-3.
Kohler et al., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256:495-7.
Koo et al., 2011, Diagnosis of IschemiaCausing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms, J Am Coll Cardiol 58(19):1989-1997.
Kozbor et al., 1984, A human hybrid myeloma for production of human monoclonal antibodies, J. Immunol., 133:3001-3005.
Kruth et al., 2003, Lasers and materials in selective laser sintering, Assembly Automation, 23(4):357-371.
Kumagai et al., 1994, Ablation of polymer films by a femtosecond high-peak-power Ti:sapphire laser at 798 nm, Applied Physics Letters, 65(14):1850-1852.
Larin et al., 2002, Noninvasive Blood Glucose Monitoring with Optical Coherence Tomography: a pilot study in human subjects, Diabetes Care, 25(12):2263-7.
Larin et al., 2004, Measurement of Refractive Index Variation of Physiological Analytes using Differential Phase OCT, Proc of SPIE 5325:31-34.
Laufer, 1996, Introduction to Optics and Lasers in Engineering, Cambridge University Press, Cambridge UK:156-162.
Lefevre et al., 2001, Stenting of bifurcation lesions:a rational approach, J. Interv. Cardiol., 14(6):573-585.
Li et al., 2000, Optical Coherence Tomography: Advanced Technology for the Endoscopic Imaging of Barrett's Esophagus, Endoscopy, 32(12):921-930.
Little et al., 1991, The underlying coronary lesion in myocardial infarction:implications for coronary angiography, Clinical Cardiology, 14(11):868-874.
Loo, 2004, Nanoshell Enabled Photonics-Based Imaging and Therapy of Cancer, Technology in Cancer Research & Treatment 3(1):33-40.
Machine translation of JP 2000-097846, Published Oct. 10, 2001.
Machine translation of JP 2000-321034, Sep. 5, 2002.
Machine translation of JP 2000-329534, Published Oct. 5, 2002.
Machine translation of JP 2004-004080, Published Aug. 1, 2004.
Maintz et al., 1998, An Overview of Medical Image Registration Methods, Technical Report UU-CS, (22 pages).
Mamas et al., 2010, Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve, Journal of Invasive Cardiology 22(6):260-265.
Marks et al., 1991, By-passing Immunization Human Antibodies from V-gene Libraries Displayed on Phage, J. Mol. Biol. 222:581-597.
Marks et al., 1992, By-Passing Immunization:Building High Affinity Human Antibodies by Chain Shuffling, BioTechnol., 10:779-783.
Maruno et al., 1991, Fluorine containing optical adhesives for optical communications systems, J. Appl. Polymer. Sci. 42:2141-2148.
McCafferty et al., 1990, Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348:552-554.
Mendieta et al., 1996, Complementary sequence correlations with applications to reflectometry studies, Instrumentation and Development 3(6):37-46.
Mickley, 2008, Steal Syndrome-strategies to preserve vascular access and extremity, Nephrol Dial Transplant 23:19-24.
Miller et al., 2010, The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome, Kidney International 77:359-366.
Milstein et al., 1983, Hybrid hybridomas and their use in immunohistochemistry, Nature 305:537-540.
Mindlin et al., 1936, A force at a point of a semi-infinite solid, Physics, 7:195-202.
Morrison et al., 1984, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, PNAS 81:6851-6855.
Munson et al., 1980, Ligand: a versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, 107:220-239.
Nezam, 2008, High Speed Polygon-Scanner-Based Wavelength-Swept Laser Source in the Telescope-Less Configurations with Application in Optical Coherence Tomography, Optics Letters 33(15):1741-1743.
Nissen, 2001, Coronary Angiography and Intravascular Ultrasound, American Journal of Cardiology, 87(suppl):15A-20A.
Nitenberg et al., 1995, Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results, Eur Heart J. 16(Suppl 1):7-21.
Notice of Reason(s) for Refusal dated Apr. 30, 2013, for Japanese Patent Application No. 2011-508677 for Optical Imaging Catheter for Aberation Balancing to Volcano Corporation, which application is a Japanese national stage entry of PCT/US2009/043181 with international filing date May 7, 2009, of the same title, published on Nov. 12, 2009, as WO 2009/137704, and accompanying English translation of the Notice of Reason(s) for Refusal and machine translations of JP11-56786 and JP2004-290548 (56 pages).
Nygren, 1982, Conjugation of horseradish peroxidase to Fab fragments with different homobifunctional and heterobifunctional cross-linking reagents. A comparative study, J. Histochem. and Cytochem. 30:407-412.
Oesterle et al., 1986, Angioplasty at coronary bifurcations: single-guide, two-wire technique, Cathet Cardiovasc Diagn., 12:57-63.
Okuno et al., 2003, Recent Advances in Optical Switches Using Silica-based PLC Technology, NTT Technical Review 1(7):20-30.
Oldenburg et al., 1998, Nanoengineering of Optical Resonances, Chemical Physics Letters 288:243-247.
Oldenburg et al., 2003, Fast-Fourier-Domain Delay Line for In Vivo Optical Coherence Tomography with a Polygonal Scanner, Applied Optics, 42(22):4606-4611.
Othonos, 1997, Fiber Bragg gratings, Review of Scientific Instruments 68(12):4309-4341.
Owens et al., 2007, A Survey of General-Purpose Computation on Graphics Hardware, Computer Graphics Forum 26(1):80-113.
Pain et al., 1981, Preparation of protein A—peroxidase mono conjugate using a heterobifunctional reagent, and its use in enzyme immunoassays, J Immunol Methods, 40:219-30.
Park et al., 2005, Real-time fiber-based multi-functional spectral-domain optical coherence tomography at 1.3 um., Optics Express 13(11):3931-3944.
Pasquesi et al., 2006, In vivo detection of exercise induced ultrastructural changes in genetically-altered murine skeletal muscle using polarization-sensitive optical coherence tomography, Optics Express 14(4):1547-1556.
Pepe et al., 2004, Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker, American Journal of Epidemiology 159(9):882-890.
Persson et al., 1985, Acoustic impedance matching of medical ultrasound transducers, Ultrasonics, 23(2):83-89.
Placht et al., 2012, Fast time-of-flight camera based surface registration for radiotherapy patient positioning, Medical Physics 39(1):4-17.
Rabbani et al., 1999, Review: Strategies to achieve coronary arterial plaque stabilization, Cardiovascular Research 41:402-417.
Radvany et al., 2008, Plaque Excision in Management of Lower Extremity Peripheral Arterial Disease with the SilverHawk Atherectomy Catheter, Seminars in Interventional Radiology, 25(1):11-19.
Reddy et al., 1996, An FFT-Based Technique for Translation, Rotation, and Scale-Invariant Image Registration, IEEE Transaction on Image Processing 5(8):1266-1271.
Riechmann et al., 1988, Reshaping human antibodies for therapy, Nature, 332:323-327.
Rivers et al., 1992, Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique, Surgery, 112(3):593-7.
Robbin et al., 2002, Hemodialysis Arteriovenous Fistula Maturity: US Evaluation, Radiology 225:59-64.
Rollins et al., 1998, In vivo video rate optical coherence tomography, Optics Express 3:219-229.
Sarunic et al., 2005, Instantaneous Complex Conjugate Resolved Spectral Domain and Swept-Source OCT Using 3×3 Fiber Couplers, Optics Express 13(3):957-967.
Satiani et al., 2009, Predicted Shortage of Vascular Surgeons in the United States, J. Vascular Surgery 50:946-952.
Schneider et al., 2006, T-banding: A technique for flow reduction of a hyper-functioning arteriovenous fistula, J Vase Surg. 43(2):402-405.
Sen et al., 2012, Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis, Journal of the American College of Cardiology 59(15):1392-1402.
Setta et al., 2005, Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis, Human Reproduction, 20(11):3114-3121.
Seward et al., 1996, Ultrasound Cardioscopy: Embarking on New Journey, Mayo Clinic Proceedings 71(7):629-635.
Shen et al., 2006, Eigengene-based linear discriminant model for tumor classification using gene expression microarray data, Bioinformatics 22(21):2635-2642.
Abdi et al., 2010, Principal component analysis, Wiley Interdisciplinary Reviews: Computational Statistics 2:433-459.
Adler et al., 2007, Phase-Sensitive Optical Coherence Tomography at up to 370,000 Lines Per Second Using Buffered Fourier Domain Mode-Locked Lasers, Optics Letters, 32(6):626-628.
Agresti, 1996, Models for Matched Pairs, Chapter 8, An Introduction to Categorical Data Analysis, Wiley-Interscience A John Wiley & Sons, Inc., Publication, Hoboken, New Jersey.
Akasheh et al., 2004, Development of piezoelectric micromachined ultrasonic transducers, Sensors and Actuators A Physical, 111:275-287.
Amini et al., 1990, Using dynamic programming for solving variational problems in vision, IEEE Transactions on Pattern Analysis and Machine Intelligence, 12(9):855-867.
Bail et al., 1996, Optical coherence tomography with the “Spectral Radar”—Fast optical analysis in volume scatterers by short coherence interferometry, Optics Letters 21(14):1087-1089.
Bain, 2011, Privacy protection and face recognition, Chapter 3, Handbook of Face Recognition, Stan et al., Springer-Verlag.
Barnea et al., 1972, A class of algorithms for fast digital image registration, IEEE Trans. Computers, 21(2):179-186.
Blanchet et al., 1993, Laser Ablation and the Production of Polymer Films, Science, 262(5134):719-721.
Bonnema, 2008, Imaging Tissue Engineered Blood Vessel Mimics with Optical Tomography, College of Optical Sciences dissertation, University of Arizona (252 pages).
Bouma et al., 1999, Power-efficient nonreciprocal interferometer and linear-scanning fiber-optic catheter for optical coherence tomography, Optics Letters, 24(8):531-533.
Breiman, 2001, Random forests, Machine Learning 45:5-32.
Brown, 1992, A survey of image registration techniques, ACM Computing Surveys 24(4):325-376.
Bruining et al., 2009, Intravascular Ultrasound Registration/Integration with Coronary Angiography, Cardiology Clinics, 27(3):531-540.
Brummer, 1997, An euclidean distance measure between covariance matrices of speechcepstra for text-independent speaker recognition, in Proc. South African Symp. Communications and Signal Processing:167-172.
Burr et al., 2005, Searching for the Center of an Ellipse in Proceedings of the 17th Canadian Conference on Computational Geometry:260-263.
Canny, 1986, A computational approach to edge detection, IEEE Trans. Pattern Anal. Mach. Intell. 8:679-698.
Cavalli et al., 2010, Nanosponge formulations as oxygen delivery systems, International Journal of Pharmaceutics 402:254-257.
Choma et al., 2003, Sensitivity Advantage of Swept Source and Fourier Domain Optical Coherence Tomography, Optics Express 11(18):2183-2189.
Clarke et al., 1995, Hypoxia and myocardial ischaemia during peripheral angioplasty, Clinical Radiology, 50(5):301-303.
Collins, 1993, Coronary flow reserve, British Heart Journal 69:279-281.
Communication Mechanisms for Distributed Real-Time Applications, NI Developer Zone, http://zone.ni.eom/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007.
Cook, 2007, Use and misuse of receiver operating characteristic curve in risk prediction, Circulation 115(7):928-35.
D'Agostino et al., 2001, Validation of the Framingham coronary heart disease prediction score: results of a multiple ethnic group investigation, JAMA 286:180-187.
David et al., 1974, Protein iodination with solid-state lactoperoxidase, Biochemistry 13:1014-1021.
Davies et al., 1985, Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, British Heart Journal 53:363-373.
Davies et al., 1993, Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content, British Heart Journal 69:377-381.
Deterministic Data Streaming in Distributed Data Acquisition Systems, NI Developer Zone, “What is Developer Zone?”, http://zone.ni.eom/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007.
Eigenwillig, 2008, K-Space Linear Fourier Domain Mode Locked Laser and Applications for Optical Coherence Tomography, Optics Express 16(12):8916-8937.
Elghanian et al., 1997, Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles, Science, 277(5329):1078-1080.
Ergun et al., 2003, Capacitive Micromachined Ultrasonic Transducers:Theory and Technology, Journal of Aerospace Engineering, 16(2):76-84.
Evans et al., 2006, Optical coherence tomography to identify intramucosa carcinoma and high-grade dysplasia in Barrett's esophagus, Clin Gast Hepat 4(1):38-43.
Fatemi et al., 1999, Vibro-acoustography: an imaging modality based on ultrasound-stimulated acoustic emission, PNAS U.S.A., 96(12):6603-6608.
Felzenszwalb et al., 2005, Pictorial Structures for Object Recognition, International Journal of Computer Vision, 61(1):55-79.
Ferring et al., 2008, Vasculature ultrasound for the pre-operative evaluation prior to arteriovenous fistula formation for haemodialysis: review of the evidence, Nephrol. Dial. Transplant. 23(6):1809-1815.
Fischler et al., 1973, The representation and matching of pictorial structures, IEEE Transactions on Computer 22:67-92.
Fleming et al., 2010, Real-time monitoring of cardiac radio-frequency ablation lesion formation using an optical coherence tomography forward-imaging catheter, Journal of Biomedical Optics 15 (3):030516-1 (3 pages).
Fookes et al., 2002, Rigid and non-rigid image registration and its association with mutual information:A review, Technical Report ISBN:1 86435 569 7, RCCVA, QUT.
Forstner & Moonen, 1999, A metric for covariance matrices, In Technical Report of the Dpt of Geodesy and Geoinformatics, Stuttgart University, 113-128.
Goel et al., 2006, Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome, Kidney Int 70(4):765-70.
Gotzinger et al., 2005, High speed spectral domain polarization sensitive optical coherence tomography of the human retina, Optics Express 13(25):10217-10229.
Gould et al., 1974, Physiologic basis for assessing critical coronary stenosis, American Journal of Cardiology, 33:87-94.
Griffiths et al., 1993, Human anti-self antibodies with high specificity from phage display libraries, The EMBO Journal, 12:725-734.
Griffiths et al., 1994, Isolation of high affinity human antibodies directly from large synthetic repertoires, The EMBO Journal, 13(14):3245-3260.
Grund et al., 2010, Analysis of biomarker data:logs, odds, ratios and ROC curves, Curr Opin HIV AIDS 5(6):473-479.
Harrison et al., 2011, Guidewire Stiffness: What's in a name?, J Endovasc Ther, 18(6):797-801.
Huber et al., 2005, Amplified, Frequency Swept Lasers for Frequency Domain Reflectometry and OCT Imaging: Design and Scaling Principles, Optics Express 13(9):3513-3528.
Huber et al., 2006, Fourier Domain Mode Locking (FDML): A New Laser Operating Regime and Applications for Optical Coherence Tomography, Optics Express 14(8):3225-3237.
International Search Report and Written Opinion dated Mar. 11, 2014, for International Patent Application No. PCT/US13/75675, filed Dec. 17, 2013 (7 pages).
International Search Report and Written Opinion dated Mar. 19, 2014, for International Patent Application No. PCT/US13/075353, filed Dec. 16, 2013 (8 pages).
Related Publications (1)
Number Date Country
20160015507 A1 Jan 2016 US
Provisional Applications (1)
Number Date Country
61785204 Mar 2013 US